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Abstract
Analyses of data with missing values often require assumptions about missingness
mechanisms that cannot be assessed empirically, highlighting the need for sensitiv-
ity analyses. However, universal recommendations for reporting missing data and
conducting sensitivity analyses in empirical studies are scarce. Both steps are often
neglected by practitioners due to the lack of clear guidelines for summarizing missing
data and systematic explorations of alternative assumptions, as well as the typical
attendant complexity of missing not at random (MNAR) models.
We propose graphical displays that help visualize and systematize the results of
sensitivity analyses, building upon the idea of “tipping-point” analysis for experi-
ments with dichotomous treatment. The resulting “enhanced tipping-point displays”
(ETP) are convenient summaries of conclusions drawn from using different modeling
assumptions about the missingness mechanisms, applicable to a broad range of out-
come distributions. We also describe a systematic way of exploring MNAR models
using ETP displays, based on a pattern-mixture factorization of the outcome distri-
bution, and present a set of sensitivity parameters that arises naturally from such a
factorization. The primary goal of the displays is to make formal sensitivity analyses
more comprehensible to practitioners, thereby helping them assess the robustness of
experiments’ conclusions. We also present an example of a recent use of ETP displays
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Abstract
in a medical device clinical trial, which helped lead to FDA approval.
The last part of the dissertation demonstrates another method of sensitivity anal-
ysis in the same clinical trial. The trial is complicated by missingness in outcomes
“due to death”, and we address this issue by employing Rubin Causal Model and
principal stratification. We propose an improved method to estimate the joint poste-
rior distribution of estimands of interest using a Hamiltonian Monte Carlo algorithm
and demonstrate its superiority for this problem to the standard Metropolis-Hastings
algorithm.
The proposed methods of sensitivity analyses provide new collections of useful
tools for the analysis of data sets plagued with missing values.
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Chapter 1
Missing Data in Empirical Studies
The best solution to handle missing data is to have none.
- R.A. Fisher
1.1 Missing Data Mechanisms
When Ronald A. Fisher and Jerzy Neyman were laying the foundation of modern
Statistics at the beginning of the 20’th century, the problem of missing data naturally
emerged from the applied work conducted by researchers in various fields. One of the
first published methods to account for missing observations was developed for field
experiments in Allan and Wishart (1930). It was later generalized in Yates (1933) and
is now regarded as a classical method of handling missing data using ANOVA (Little
and Rubin 2002, p. 28). M’Kendrick (1925) studied numerous medical data and,
when calculating the infection rate in the population, proposed a method to solve the
issue with unobserved exposure indicator. His approach was later recognized to be a
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special case of one of the most widely used methods of handling data with missing
values, the EM algorithm (Dempster et al. 1977; Meng 1997). Wilks (1932) was the
first to formally employ method of maximum likelihood, introduced by R. A. Fisher
a decade earlier, to provide inference on population parameters in a bivariate normal
setting with missing observations.
R. A. Fisher, the greatest statistician of his time, was undoubtedly right by imply-
ing that the most effort should be devoted to prevention of missing data. However,
it is almost inevitable that the issue will come up in applications, and most data
analysis procedures are not designed to handle it. The problem of non-random at-
trition and nonresponse1 in survey research as well as missing data in randomized
experiments has been widely addressed in the literature (Rubin 1987; Schafer 1997;
Little and Rubin 2002; Allison 2001; McKnight 2007). Nevertheless, up until a half
a century later, missing values in applied work were handled primarily by editing or
case deletion (Schafer and Graham 2002). Only with the formalization of a frame-
work of inference from incomplete data developed in Rubin (1976), the research of
methods to handle missing data began to gain momentum.
Missing data pose a major problem for experiments as well as observational stud-
ies. If proper randomization was performed, the presence of missing data jeopardizes
the original balance of the design and may lead to invalid inferences if not handled
properly. Observational studies also suffer from missing data in covariates that are
believed to be important in predicting the treatment and outcome, or in the out-
come itself, especially if the missing data mechanism is unknown, which is usually
1Here and throughout the article we assume item nonresponse, implying that some information
about each missing unit is available.
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the case. Improper analysis of incomplete data can result in reduced statistical power,
decreased generalizability of findings, and biased parameter estimates.
Here we adopt a standard approach to define and classify missing data. A value is
considered missing if it is potentially observable and meaningful for analysis, although
not available in the data set at hand. With N units in the dataset, let X = (xik) =
(X 1,X 2, . . . ,XK) be the NxK matrix of baseline variables (covariates, or predictors),
and let Y = (yij) = (Y 1,Y 2, . . . ,Y J) be the NxJ matrix of outcome measures (or
dependent variables). It is important to distinguish missingness in baseline predictors
and in outcomes because it may have to be handled differently (Little 1992; Moons
et al. 2006; Newgard and Haukoos 2008).
We define a matrix of missingness indicators for the outcomes, DY = (dij), such
that dij = 1 if unit i is missing the jth outcome. Analogously, a matrix of miss-
ingness indicators for the baseline variables is defined as DX = (dik), and we let
D = (DX ,DY ). The paramount idea introduced in Rubin (1976) suggests that we
need to regard the dij as random variables, and offers a straightforward way to define
missing data mechanisms through distributions on the dij.
Let a set Y obs = {yij | dij = 0} contain the observed values among the out-
comes, and a set Y mis contain the missing elements of the matrix Y , such that
Y = (Y obs,Y mis); note that Y obs and Y mis are not matrices, but rather collections of
elements of the matrix Y , where, formally, the sets obs and mis are functions of DY .
Analogous sets can be defined for the matrix of baseline variables, X = (X obs,Xmis).
Also, let f(D |X,Y ;φ) be the conditional distribution of missingness indicators given
all data values, observed and missing, and unknown vector-parameter φ.
3
Chapter 1: Missing Data in Empirical Studies
The missingness mechanism is called missing completely at random (MCAR) if,
for each possible value of φ,
f(D | X,Y ;φ) = f(D | φ) for all D, X , and Y .
In other words, in a simple case with one vector of outcomes and no predictors (K = 1
and J = 0), missing values can be viewed as randomly deleted. However, in higher
dimensions, K > 1 or J > 0, or both, it is allowed for the missingness indicators to
interact, though independently from the data.
It is rarely the case that the MCAR assumption holds in practice. One scenario
where the MCAR assumption is plausible is when the data were deliberately not
collected, or missing by design (Rubin 1987). The less restrictive missing at random
(MAR) assumption holds if, for each possible value of φ,
f(D | X,Y ;φ) = f(D | X obs,Y obs;φ) for the observed D, X obs, and Y obs,
and for all Xmis and Y mis, i.e., if the distribution of missingness indicators depends
only on the observed covariate and outcome values. Although this is how MAR
assumption was defined originally in Rubin (1976) for the purpose of Bayesian or
direct-likelihood inference, it is sometimes mistakenly employed for sampling distri-
bution (or frequentist) inference based on a large-sample theory, e.g., constructing
confidence intervals (see Heitjan and Basu 1996).
A stochastic generalization of MAR that allows to utilize frequentist inference,
called a “MAR mechanism” in Little and Rubin (1987), was formally called missing
4
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always at random (MAAR) in Mealli and Rubin (2013), which holds if the following
is true:
f(D | X,Y ;φ) = f(D | X obs,Y obs;φ) for all D, X and Y ,
and for each possible value of φ. In other words, the missingness should depend on
the observed data only, and it should hold for all realizations of the missing-data
pattern D and random variables X and Y , not just for the observed ones. This
condition requires analysts to consider a hypothetical missingness mechanism even
in cases when all values in the data were observed, as long as some of them could
potentially have been missing. However, MAR would hold if, for units with covariate
or outcome missingness depending on the underlying values, all values were observed
in a current realization. In addition, Little (1995) introduced the term covariate-
dependent (CD) missingness for situations with no missingness in predictors (X =
X obs). CD missingness is a special case of MAAR when the missingness mechanism
depends only on predictors and not on the outcomes, i.e.,
f(D | X obs,Y ;φ) = f(D | X obs;φ) for all D, X obs and Y ,
for each possible value of φ. In fact, this assumption is the one most commonly used
in practice, although many studies erroneously report using MAR assumption.
Assume that the joint distribution of outcomes Y and predictors X has a prob-
ability model f(Y ,X | θ), governed by unknown vector-parameter θ, and suppose
we are interested in estimating θ. The missing data are said to be ignorable for the
purpose of likelihood-based inference for θ if MAR is satisfied and parameters φ carry
5
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no information about θ (i.e., φ and θ are distinct2, Rubin 1976; Little and Rubin
2002). The term “ignorable” comes from the fact that f(D | X obs,Y obs;φ) may be
“ignored” (or dropped) from the likelihood without altering the likelihood function
(or posterior distribution) of θ.
If either the distinctness of φ and θ or MAR is not met, missing data are considered
nonignorable. Violation of distinctness is less consequential than violation of MAR,
because the likelihood-based inference will still produce consistent, although generally
inefficient, estimates, whereas, violation of MAR is often critical (see Appendix A.1
for an example of nonignorable MAR mechanism). If the missingness mechanism does
not satisfy MAR, it is regarded as missing not at random (MNAR). Analysis of data
with MNAR missingness requires specifying a full-data likelihood f(Y ,D,X | θ,φ),
including a model for the missingness mechanism f(D | X,Y ;φ), in order to produce
a generally valid likelihood-based inference. In practice, these models require making
assumptions about the distribution of missing values that often cannot be assessed
empirically, and, therefore, the obtained results should be subjected to sensitivity
analyses.
1.2 Parameter Estimation with Incomplete Data
The most basic approach to handle data with missing values is complete-case
(listwise deletion) or available-case (pairwise deletion) analysis. However, quite a few
research articles were written about the shortcomings of this approach (e.g., Rubin
2I.e., are in disjoint parameter spaces; the concept can be extended to Bayesian inference by
requiring two vector-parameters, θ and φ, to be a priori independent.
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1987; Greenland and Finkle 1995; Schafer and Graham 2002; van der Heijden et al.
2006; Carpenter and Kenward 2008; Liublinska and Rubin 2012).
Many superior methods were developed during a second half of the 20th century.
One class of methods utilizes the idea introduced by Horvitz and Thompson (1952),
which suggests weighting responses by inverse-probability of observation to produce
unbiased estimate of population averages (?Little and Rubin 2002, section 3.3). One
can think of this procedure as a reconstruction of the population of interest, with
each weight corresponding to an approximate number of units in the population that
the observed response represents.
The Horvitz-Thompson estimator was originally proposed for analysis of surveys
with sampling weights set in advance and the estimator is most efficient when the true
weights are known. However, in observational studies it is largely impossible to know
the missingness mechanism exactly and weighting methods require modeling response
probabilities using available covariates. Estimates based on weighting responses by
the estimated propensity to respond can be very unstable; they rely heavily on the
validity of the proposed propensity model. In addition, if very few respondents are
similar to nonrespondents, they would have a disproportionately large effect on the
estimate, resulting in large uncertainty bounds. Inference from this class of methods
is mainly focused on marginal population characteristics, e.g., average response, al-
though it can be extended to consistently estimate parameters from the conditional
distribution f(Y | X ;θ) (Robins et al. 1994, 1995). In addition, by incorporating a
model for the response itself, doubly-robust estimators can be constructed (see ?, for
an extensive review).
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A few model-based approaches to draw valid inferences in the presence of missing
data have been developed over the last several decades. One is based on specifying
full (or observed) likelihood of the data and performing MLE estimation using various
maximization methods, including expectation-maximization (EM) (Dempster et al.
1977), Newton-Raphson, or scoring algorithms. A Bayesian analog of this estimation
approach extends the model by adding a prior component for parameters θ and φ,
p(θ,φ), and estimating their joint posterior distribution p(θ,φ | Y ,X,D) (Tanner and
Wong 1987).
The full-likelihood approach is quite complex analytically and computationally;
it requires joint parametric modeling of the data-generating process and, sometimes,
the missing data mechanism too. In the EM algorithm, the M-step may be hard to
formulate and the convergence to the maximum can be particularly slow if the fraction
of missing information is large. However, if the model is specified correctly, MLE
estimate has attractive large-sample properties, including consistency, asymptotic
normality and asymptotic efficiency.
Another class of methods recommends imputing each missing response. Then, any
quantity of interest from the conditional (and marginal) distribution of the response
can be easily obtained from a resulting rectangular dataset. Imputation methods can
be classified into model-based and hot-deck. The former class utilizes the relationship
between the response and available covariates. Consequently, the estimates strongly
depend on the accuracy of the model. The hot-deck class offers procedures to match
the respondents and nonrespondents and impute the missing responses by drawing
from a “donor pool” of units with observed responses (e.g., exact matching, predictive
8
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mean matching (Rubin 1986; Little 1988a), propensity score matching (Little 1986),
etc.). Note that all these methods require substantial overlap between respondent’s
and nonrespondent’s covariates, a problem that we cover in details in Section 1.3.2
below.
Some imputation methods involve producing single imputation for each missing
value, e.g., mean substitution, regression substitution, worst-case substitution, last
observation carried forward (LOCF). Although there are settings where these methods
will result in valid inferences, they require strict assumptions that are, often, unre-
alistic (Little and Rubin 1987, 2002; Rubin and Schenker 1991; Little 1992; Schafer
1997, 1999; Donders et al. 2006).
A more general imputation approach that has been gaining momentum over the
last decade is multiple imputation (MI, Rubin 1987), i.e., creating multiple com-
pleted datasets by imputing missing values from their posterior predictive distribution
f(Y mis,Xmis | Y obs,X obs;θ,φ). If the data (Y ,X ) are jointly normally distributed,
the posterior predictive distribution for missing values is easily derived. However,
often it is too difficult to obtain f(Y mis,Xmis | Y obs,X obs;θ,φ) in a closed traceable
form and a convenient algorithm was developed to provide a way to approximate the
posterior predictive distribution for missing values without the need to put a model on
a full joint distribution of Y , X andD. The algorithm consists of iterating a sequence
of univariate regression models for imputation (Raghunathan et al. 2002), also known
as “multivariate imputation by chained equations” (MICE, Rubin 2003; Buuren van
and Groothuis-Oudshoorn 2011; Buuren 2012). It involves performing univariate im-
putations iteratively, each time fitting a model to a variable with missing values,
9
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conditional on all others included in the analysis. A variable with newly imputed
values is conditioned on in subsequent iterations, and the procedure cycles though
all variables with missing values until the convergence of the sampling distribution of
imputed variables is achieved.
The advantage of MI is that it enables practitioners to use widely-available complete-
data methods on each imputed dataset separately and incorporate the uncertainty
due to the presence of missing data by pooling the results using Rubin’s Combining
Rules (Rubin 2004). More important, this method is very suitable for performing
sensitivity analyses, because one can use multiple models to generate imputations
and compare conclusions across the models. In Section 3.3 we show how MI can
be utilized to explore the consequences of alternative assumptions about the missing
data mechanism.
Despite a plethora of available methods to produce valid inference for incomplete
data, to this day, very few empirical studies acknowledge this issues and, even less,
handle it properly. As we show next, there are no agreed upon guidelines on reporting
the amount and the characteristics of missing data in a study, and the decision to
report them is usually made at the practitioner’s discretion. As a result, even when
study reports indicate that some data are missing, most of them do not discuss
assumptions that were made regarding the missing data or missingness mechanisms,
nor do they include any sensitivity analyses.
10
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1.3 Standards of Missing Data Reporting
A major breakthrough was made in the ways missing data are handled in empirical
studies due to the effort of many outstanding statisticians to study and explain the
extent of the issue to practitioners. It is now a common knowledge that reporting
the presence of missing data is necessary, although still seldom done in practice,
and an increasing number of studies attempt to employ the methods described in
Section 1.2 to account for the missingness. However, there are very few explicit
reporting guidelines, approved and agreed upon in statistical community, available
for analysts who work on studies with missing data. This shortcoming results in lack
of structure in reporting practices observed throughout the literature. The danger
is that haphazard and fragmented description of missing data may result in a false
assurance in study’s conclusion.
Several revealing surveys of articles in empirical research journals were conducted
in recent years. Their objective was to study missing data prevalence, reporting,
and handling practices, and their conclusions were worrisome, but promising. For in-
stance, White et al. (2011) reviewed randomized controlled trials published in major
medical journals in 2001. Out of 71 trials that were surveyed, 89% reported having
partly missing outcome data. Among those, 65% performed complete case analysis,
most of the rest performed single imputation, and only 21% conducted some sensi-
tivity analysis. Klebanoff and Cole (2008) and Mackinnon (2010) focused on studies
that used MI and concluded that, although MI is becoming more common in med-
ical studies, clear guidelines of reporting MI procedure should be developed. Other
surveys of clinical studies (Burton and Altman 2004; Aylward et al. 2010) reported
11
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similar observations.
The situation is more alarming in social sciences. Bodner (2006) reported that,
in a random sample (N = 181) of empirical studies taken from almost 36,000 articles
identified in PsycINFO database (that contains studies in social and behavioral sci-
ence research) in 1999, two-thirds either did not have missing data or failed to report
them completely. Among the rest, only half explicitly discussed missing data in the
text, and a vast majority (97%) did not account for them in any way (i.e., used either
complete-case or available-case analysis). See also Jelicic et al. (2009) for a review of
similar studies.
Another article Peugh and Enders (2004) provided a much larger methodological
review of missing-data reporting practices in 23 applied educational and psychological
journals published in 1999 and 2003 (around 1, 500 articles in total). The findings for
1999 were consistent with the ones reported in Bodner (2006), i.e., “details concerning
missing data were seldom reported” and methods used to address the issue were
rudimentary. Conclusions from articles published in 2003 were more optimistic: half
of studies had some indication of the presence of missing data and most of those
explicitly discussed the problem in the text. The authors attribute this improvement
to a previously published report by the American Psychological Association (APA)
Task Force on Statistical Inference (Wilkinson 1999), which provided many important
guidelines on current practices of data analysis. However, a thorough review of the
report identified only one sentence that touches upon the missing data issue: “Before
presenting results, report complications, protocol violations, and other unanticipated
events in data collection. These include missing data, attrition, and nonresponse”.
12
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Although the message is important, more details are needed.
The most complete and up-to-date report on the issue of prevention and treatment
of missing data (focusing on clinical trials) was assembled by the National Academy
of Sciences at the request of the U.S. FDA (NRC-Panel 2010). Although the authors
gave full and detailed account of modern techniques for handling missing data, sur-
prisingly little attention was devoted to standardizing their reporting. Evidently, it
reflects lack of research in this area, as authors themselves admitted the need for more
standardized documentation and analysis of the reasons for missing data (NRC-Panel
2010, p.112).
Current industry standards of reporting randomized trials (Schulz et al. 2010) re-
quire researchers to disclose the number of excluded participants after randomization
and the reasons for the exclusion, without any more details. Below we demonstrate
that further analysis of characteristics of the study participants with missing obser-
vations, as well as the exact time of their dropout, may be crucial in assessing the
appropriateness of chosen missing-data techniques, including checking if the required
assumptions are scientifically justifiable.
A unique report that provides a more rigorous treatment of the process of missing
data exploration was issued by the European Medicines Evaluation Agency (EMEA,
CHMP 2010). This report emphasizes the importance of a thorough discussion of the
amount, reasons, timing, and pattern of missing data, and possible implications of
having it. Although many crucial reporting elements were emphasized, the practical
advice was still sparse. Next we discuss some elements mentioned in guidelines issued
by EMEA, expand upon them and present formal and graphical methods that can be
13
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used to report missing data in empirical studies.
1.3.1 Important Missing Data Summaries
Every report that documents an empirical study usually contains a section on data
description. It is crucial for the information about missing observations to become
an essential part of this section. Below we list several recommendations on the most
important components that must not be omitted from the report, with brief reasoning.
Missingness rates. The basic statistics that provide initial idea of the amount
of missingness are proportions of missing values observed in each variable (possibly by
treatment arm, if applicable). In fact, missing data indicators may be considered as
additional outcomes, especially if missingness rates are substantially different across
treatment arms. For example, in a clinical trial setting, they may be a proxy for
patient’s tolerance levels and treatment preference. Rates that are much higher than
the difference in success rates between treatment groups may lead to a rejection of
the trial by the FDA (NRC-Panel 2010).
Reasons for missingness. This information should play a major role in assessing
and justifying assumptions about missing data employed in a study. Attention should
be paid to reasons that relate missingness mechanism to the unobserved data. For
example, survey participants refusing to respond due to the sensitive nature of the
question (e.g., if some answer choices are controversial), patient dropout initiated by
an adverse side effect of a new drug, or measurement censoring due to malfunction of
a measuring device. These are just a few situations where the assumption of ignorable
missing data would be inappropriate.
14
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Note that the information about reasons for the missingness may help rule out
MCAR or MAR assumptions, however it will not be sufficient to validate either of
them. In general, it is difficult to fully justify ignorability assumption using available
data only (Rubin 1976). It was shown that models based on MAR and MNAR as-
sumptions could have comparable fits to the observed data but substantially different
predictions for the missing part (Molenberghs et al. 1999). The decision for or against
ignorability should be made after acquiring a sufficient understanding of the scientific
aspect of the problem and consulting with collaborators acquainted with the field.
Studying times of dropout and reasons for it in randomized studies also
helps to understand the missing data pattern. Committee of Health and Medicinal
Products (CHMP 2010) recommended ways of summarizing the pattern of drop-outs
using graphical displays. In longitudinal studies, Kaplan−Meier plots can be used to
compare the time to withdrawal between each treatment group, possibly grouped by
reasons. The authors also emphasized that baseline and post-baseline characteristics
of subjects who discontinued and who completed the trial should be compared. This
important detail is being overlooked in virtually every empirical study and we discuss
it in details below.
Differences in baseline characteristics. Both CHMP (2010) and Burzykowski
et al. (2010) briefly mentioned the importance of checking for any differences observed
between respondents and nonrespondents, and here we elaborate on it and provide
some practical advice. Peugh and Enders (2004) reported small but positive shift in
the prevalence of testing MCAR assumption in 2003 sample of studies compared to
the 1999 one. In fact, this is the only assumption that can be tested explicitly, even
15
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if there are no fully observed covariates for all units (Little 1988b); any substantial
differences observed between respondents and nonrespondents within any treatment
group immediately exclude MCAR assumption. Besides, the size of the difference
alerts us about a potential extrapolation that may take place if the inference is drawn
for all subjects, including the nonrespondents, especially if the procedure relies on the
observed data only. In the following section we describe a set of analytic and graphical
methods for comparing various characteristics of respondents and nonrespondents and
reporting found imbalances.
The above list is not exhaustive and there may be other study-specific informa-
tion crucial to disclose. However, it contains some of the most important components
that help to choose the appropriate way to handle missing data. In addition to the
initial summaries, the detailed description of methods used to address missing-
ness should be included in the analysis section, along with assumptions that were
employed, their justification and appropriate references.
Finally, every reviewed guideline especially stressed the significance of performing
sensitivity analyses that assess the impact of missing data on reported estimates and
conclusions. In Chapters 2 and 3 we propose a convenient model-based procedure
for conducing sensitivity analyses in studies with two treatment arms, incorporating
graphical displays.
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1.3.2 Assessing the Overlap Between Respondents and Non-
respondents
Here we focus on one of the most informative, but rarely studied, features of
units in a study with missing data, namely, the extent to which the units with and
without missing data look alike. Most software packages that perform missing data
imputation automatically do not alert a user if the characteristics of respondents and
nonrespondents are very dissimilar. Moreover, hardly any article that discusses meth-
ods of addressing missing data issues stresses the necessity of measuring the overlap
between the characteristics of missing and observed units before conducting the anal-
ysis. However, if there is little overlap then the inference will require extrapolation.
For simplicity, we assume that there is no missing data in covariates (X = X obs,
D = DX) and that the outcome is univariate (J = 1, extensions to incomplete
multivariate outcomes are discussed as well). Suppose that units are independent and
exchangeable, which allows us to drop the index “i”, i = 1, . . . , N , and that f(x | ν)
is the joint probability distribution of covariates for each unit, where ν is a vector of
parameters. We showed in Section 1.1 that, by definition, MCAR assumption holds
if the distribution of the missingness indicator d does not depend on any observed
data, i.e., f(d | x;ν) = f(d | ν). Therefore, it follows that
f(x | d;ν) = f(x, d | ν)/f(d | ν)
= f(d | x;ν)f(x | ν)/f(d | ν)
= f(x | ν).
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Thus, the joint distribution of covariates for nonrespondents, f(x | d = 1;ν), is the
same as the one for respondents, f(x | d = 0;ν). This fact can be used to construct
a wide variety of tests and graphical summaries to verify the MCAR assumption.
Moreover, even if we conclude that the MCAR assumption is not justified, the results
of these tests can help us to assess the amount of extrapolation that will occur if MAR
(or MNAR) assumption is used instead. For example, in Section 2.3.2 we present data
from a randomized clinical trial, where some groups of subjects with missing outcomes
did not resemble any of the subjects with fully observed outcomes. We used these
discrepancies to conduct further sensitivity analyses of the study’s conclusions. Next,
we describe several analytical and graphical methods that can be used to quantify
and qualify the overlap between respondents and nonrespondents.
Analytical methods. A straightforward way of comparing units with and with-
out missing outcomes consists of comparing the distribution of fully-observed covari-
ates one at a time as well as their two-way interactions (or any other function of
x). Standard tests, such as t-test for means or z-test for proportions, F -test for vari-
ances, and Kolmogorov-Smirnov test for empirical distributions, can be used in any
combination, depending on the distributions of covariates under consideration.
The next step is to consider summaries based on all covariates for respondents
and nonrespondents, comparing features of their joint distributions. For instance,
for a subset of covariates whose joint distribution resembles a Multivariate Normal
distribution we can calculate the Mahalanobis distance between the group means,
H2 = (x¯1 − x¯0)
′
Cˆ−1 (x¯1 − x¯0) ,
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where x¯0 and x¯1 are vectors of sample means of covariates for respondents and non-
respondents, respectively, and Cˆ is the estimated pooled covariance matrix. Various
test statistics have been developed to test if the underlying populations’ means are
equal (e.g, Hotelling T 2, Hotelling 1931; Cacoullos 1965a,b).
Finally, many tests were proposed to check the MCAR assumption in situations
with missingness in more than one variable. Majority of them propose testing homo-
geneity of means and covariances among the multiple groups of data, distinguished
by their missing data patterns, i.e., groups of units that have missing values in the
same set of variables, (e.g., Little 1988b; Kim and Bentler 2002; Jamshidian and Jalal
2010). Several R-packages were created to facilitate testing MCAR assumption, e.g.,
MissMech, BaylorEdPsych.
Graphical methods. Remarkably, some ideas for comparing the subgroups of
respondents and nonrespondents can be borrowed from the theory of unit-matching
in causal inference (Rubin 2006b). Indeed, the procedures for checking balance be-
tween matched treated and control units have the same goal, i.e., to ensure that joint
distributions of covariates are sufficiently similar.
First obvious step is to compare histogram shapes and check the difference in
ranges. An effective method of assessing the balance visually, so called Love plots,
was introduced by Thomas E. Love (Ahmed et al. 2006; D’Agostino Jr. 1998). The
plots display standardized differences in average covariate values between two groups,
calculated for discrete and continuous variables as follows:
dc =
100 (x¯1 − x¯0)√
(σˆ21 + σˆ
2
0) /2
, db =
100 (pˆ1 − pˆ0)√
(pˆ1(1− pˆ1) + pˆ0(1− pˆ0)) /2
.
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Generally, absolute standardized differences above 10% indicate serious imbalance.
These plots are utilized in the example in Section 2.3.2 below to check the balance
between covariates for units from two treatment arms. The R-package RItools (func-
tion plot.xbal, Hansen and Bowers 2008) can be used to draw Love plots.
Another idea that can be borrowed directly from the matched sampling is checking
the balance in propensity scores (Rosenbaum and Rubin 1983, 1985). Here we define
a propensity score as p = P (d = 1 | x;φ), a probability to be missing. After fitting
the model for d | x,φ, one can examine the overlap between empirical distributions of
propensity scores for respondents and nonrespondents as well as test for differences
in the distributions of p|d = 1 and p|d = 0 (possibly, on a logit scale) analytically.
Displaying multivariate data on a graph is especially challenging, and one plot
type that does it effectively is parallel coordinate plot. It represents all variables
(usually scaled to fall in [0, 1] interval) by parallel vertical bars, and observations
corresponding to each unit are connected by lines. These plots can be produced using
the R-package VIM (Templ and Filzmoser 2008), which is devoted solely to creating
various visualizations of missing values in a dataset to help explore their patterns.
Figure 1.1 shows an example or the parallel coordinates plot, borrowed from (Templ
and Filzmoser 2008).
The next two chapters describe a new systematic way to perform sensitivity anal-
yses in studies with missing data by incorporating graphical displays.
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Figure 1.1: An example of the parallel coordinates plot taken from Templ and Filz-
moser (2008). Here, the color indicates units with missing values in the variable
py050n. We can notice that units with missing py050n have high portion of small
values in the variable P033000, and P029000 = 0 for all of them. Also, some cate-
gories of P001000 and bundesld do not have any units that are missing py050n, and,
for the variable pek g, nonrespondents fall only in a certain range.
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Sensitivity Analysis for Partially
Missing Binary Outcomes in a
Clinical Trial with Two Arms
2.1 Introduction
Various methods of handling data with missing values have been proposed in the
literature. Each one of them requires assumptions about the missingness mechanism,
implicit or explicit, and full appreciation was not given to the importance of these
assumptions until the pivotal work of D. Rubin in the 1970s. As described in Section
1.1, Rubin (1976) proposed to treat missingness indicators as random variables, and,
since then, three missingness mechanisms were defined, MCAR, MAR, and MNAR.
Here we focus on a special but very common case when the outcome data is
partially missing and a set of fully-observed predictors that explain the missingness
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and the outcomes is available. Let Y = (y1, . . . , yN)
′, where yi denotes a value of a
univariate outcome of interest for unit i, and let D = (d1, . . . , dN)
′ be the missingness
indicator, such that di = 0 for units that are missing yi and di = 1 for units with
observed yi. LetX = (xi,j) be a set of predictors that consists of three nonoverlapping
subsets: predictors XY of the response Y only, predictors XD of the missingness
indicator D only, and common predictors XY D for Y and D, such that XY , XD,
and XY D do not overlap. The triplet (xi, yi, di) is assumed to be independent and
exchangeable across units, so we drop the index i to keep the notation in this section
uncluttered.
Let the probability distribution of the outcomes for each unit be
f(y | x,θ) = f(y | xY ,xY D;θ)
and the probability distribution of the missingness indicator be
f(d | x, y,φ) = f(d | xD,xY D, y;φ),
where θ and φ are vector-parameters governing the corresponding distributions. Then,
each missingness mechanism defined in Section 1.1 implies that the following holds
for every unit:
• MCAR: f(d | xD,xY D, y;φ) = f(d | φ) for each φ and for all x and y. In other
words, XD and XY D are empty sets and the missingness is independent of the
response y itself.
• MAR: f(d | xD,xY D, y;φ) = f(d | xD,xY D;φ) for the observed d, x, and y, and
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for each φ.
• MNAR: f(d | xD,xY D, y;φ) 6= f(d | xD,xY D;φ). Note that MNAR can im-
ply that there is an unobserved variable u that is associated both with the
response and with the missingness indicator, such that f(d | xD,xY D, u, y;φ) =
f(d | xD,xY D, u;φ), but, because we failed to measure u, the model for the
missingness mechanism requires conditioning on the response y itself.
Definitions of all three missingness mechanisms do not assume anything about the
distribution of the outcome y, so that it does not even have to be a random vari-
able (Rubin 1976). However, here we specifically focus on the situation where the
distribution of the outcome is modeled using covariates X .
Figure 2.1 displays graphically the three mechanisms described above. The top
row shows available predictors, and the bottom row shows outcomes. Conditional
dependencies are represented by lines, while the absence of a line indicates conditional
independence between the corresponding variables. Here, the dependency between
variables is not limited to a linear model, as in Cox and Wermuth (1993), nor does a
line suggest any causal relationship, as in Pearl (2009).
Many studies with missing data either use complete-case analysis (i.e., discard
units with partially missing data), which is generally invalid, except in very special
cases of MCAR mechanisms, or choose to analyze the data under the MAR assump-
tion. The latter is usually a more sound approach than the former, especially when
the MCAR assumption is contradicted by the observed data. At the same time, the
MAR assumption allows us to avoid specifying a model for missingness mechanism
for Bayesian or direct-likelihood inferences, assuming φ and θ are distinct (see Section
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(a) MCAR (b) MAR (c) MNAR
Figure 2.1: Illustration of the types of missingness mechanisms introduced in Section
1.1 for a special case with univariate outcome and no missingness in covariates. Panel
(a) shows that, under MCAR, xY D is empty and d is not related to y. Panel (b)
indicates that, for MAR, d is allowed to be associated with y through the mutual
predictors xY D. As evident from the diagrams, MCAR assumption is a special case
of MAR . Finally, panel (c) shows that MNAR includes all cases that are not MAR.
1.1). However, although the MCAR assumption may be tested empirically (see Sec-
tion 1.3.1, Rubin 1976; Little 1988b), the MAR assumption is generally unassessable.
Therefore, a thorough sensitivity check is necessary to assess the influence of various
assumptions about the missingness mechanism on study conclusions.
Here, focusing on binary outcomes, we describe a set of convenient displays that
reveal the effects of all possible combinations of the values of missing data in treat-
ment and control groups on various quantities of interest, typically, on p-values and
point estimates. The displays are based on the idea of “tipping-point” analysis, first
introduced in Yan et al. (2009), but anticipated in Matts et al. (1997), Hollis (2002),
and Weatherall et al. (2009), as a method of assessing the impact of missing data on
study’s conclusions about some quantity of interest.
Tipping points of a study are defined as particular combinations of missing data
values that would change the study’s conclusions. Yan et al. (2009) presented a
simple way to display these combinations for studies with two arms and a binary
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outcome. We enhance this initial idea by adding more details onto the display. In
particular, we allow for smooth changes in quantities of interest, add the output from
multiple missingness models, including MNAR, and, when available, mark historical
estimates. We show how the display can help to systematize the sensitivity analyses
and to demonstrate the results across different alternative models. The proposed
displays enable practitioners to identify how close alternative assumptions about the
missingness mechanism come to altering the study’s conclusions and, thereby, to
assess the strength of the study’s evidence.
The rest of the chapter is organized as follows. Section 2.2 lays out the basics
of the sensitivity analysis and the motivation for the proposed technique. Section
2.3 provides a detailed description of enhanced tipping-point displays for a binary
outcome. It also includes a simulated example that demonstrates the technique and
a real-data example of the recent use of the enhanced displays in a medical device
clinical trial. We conclude with a discussion (Section 2.4).
2.2 Sensitivity Analyses for Studies with Missing
Data
In every empirical study plagued with missing data, researchers face a tough deci-
sion about the method of handling it. The choice of the method should be justified by
stating and discussing the required assumptions and, possibly, applying alternative
methods to assess the extent to which the study conclusions depend on the assump-
tions used. The latter constitutes the essence of a sensitivity analysis for studies with
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missing data, which is especially necessary if the assumptions about the missingness
mechanism used in the study are unassessable, which is typical.
A sensitivity analysis consists of several steps:
• Formulating conclusions under working assumptions;
• Identifying a set of plausible alternative assumptions;
• Studying the variation in the statistical output and conclusions under these
alternative settings.
Because many methods for handling missing assume a MAR mechanism, the last two
steps imply weakening this assumption. However, the apparent complexity of MNAR
models appears to be the primary reason why the majority of empirical research
chooses to omit any sensitivity analysis altogether. Yet, in some cases, omitting it is
not an acceptable option, especially when it comes to important decisions like approv-
ing a drug or a medical device, or implementing a new public policy. For example,
NAS report on methods of handling missing data (NRC-Panel 2010, p. 5) made the
following recommendation: “Recommendation 15: Sensitivity analyses should be part
of the primary reporting of findings from clinical trials. Examining sensitivity to the
assumptions about the missing data mechanism should be a mandatory component of
reporting.” Other guidelines issued lately (Burzykowski et al. 2010; CHMP 2010) also
stressed the need to perform sensitivity analyses that assess the impact of missing
data on reported inferences and conclusions.
In spite of the rising demand, there is clearly a shortage of practical recommenda-
tions as to how one should perform sensitivity analyses (Lee 2007; NRC-Panel 2010).
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As pointed out in NRC-Panel (2010, p. 83), “Unlike the well-developed literature on
drawing inferences from incomplete data, the literature on the assessment of sensitiv-
ity to various assumptions is relatively new. Because it is an active area of research,
it is more difficult to identify a clear consensus about how sensitivity analyses should
be conducted.” We address this issue below and demonstrate a process of exploring
MAR and MNAR models for studies with missing values in binary outcomes using
enhanced tipping-point displays.
2.3 Enhanced Tipping-Point Displays for Studies
with a Binary Outcome
Tipping-point (TP) analysis was first proposed in Yan et al. (2009) to aid clinical
reviewers in judging the impact of missing data in the outcome on the estimation of
a treatment effect. Yan et al. (2009) constructed displays to help illustrate “tipping
points” of a study, i.e., the combination of possible values of missing outcomes that
would reverse the conclusion about the statistical significance of the treatment effect.
These displays were further discussed in Campbell et al. (2011) as a convenient tool
to reveal the results of sensitivity analysis to various deviations from assumptions
made about the missing data mechanism.
Suppose that a study is conducted to estimate the effect of a vaccine (or a treat-
ment) on a subsequent occurrence of a disease. A total of N study subjects are
divided into treatment group or control group, and a (2 × N) set of predictors X ,
along with a vector of treatment indicators T = (t1, . . . , tN)
′, are completely observed
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for all subjects. A vector of outcomes Y = (y1, . . . , yN)
′ indicates whether each sub-
ject developed the disease (“success”) or not (“failure”) and some subjects are missing
the outcome, as indicated by the vector of missingness indicators D = (d1, . . . , dN)
′.
Vector Y has four parts that correspond to observed and missing outcomes among
treatment and control subjects, i.e., Y Tobs, Y
C
obs, Y
T
mis, and Y
C
mis, such that
Y =
 Y T
Y C
 ,Y T =
 Y Tobs
Y Tmis
 ,Y C =
 Y Cobs
Y Cmis
 .
Let τ = E(yi | ti = 1, θ) − E(yi | ti = 0, θ) be a marginal average treatment ef-
fect, identical for all subjects i = 1, . . . , N . If the treatment is properly randomized
between the subjects, an unbiased estimator of τ is
τˆ =
∑
i:yi∈Y T
yi/N
T −
∑
i:yi∈Y C
yi/N
C = y¯T − y¯C , (2.1)
where NT and NC are the sample sizes for treatment group and control group re-
spectively.
For a binary outcome Y , an intuitive summary of missing values is the number of
successes among subjects with missing outcomes, considered separately for treatment
group and control group,
g(Y Tmis) =
∑
i:yi∈Y Tmis
yi = N
T
misy¯
T
mis, g(Y
C
mis) =
∑
i:yi∈Y Cmis
yi = N
C
misy¯
C
mis,
where NT = NTmis + N
T
obs and N
C = NCmis + N
C
obs. Moreover, these summaries are
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Figure 2.2: This illustration is taken from Campbell et al. (2011) to demonstrate
the idea proposed in Yan et al. (2009). The horizontal and vertical axes indicate
the number of successes that can potentially be observed among nonrespondents in
the treatment group and the control group. Each combination is marked as either
“altering the study’s conclusion” (lighter squares) or “keeping the study’s conclusion
unchanged” (darker squares). The staircase region indicates the tipping points of the
study.
justified by the fact that, for N i.i.d binary variables with probability of success p,
y1, . . . , yN | p ∼ Bern(p),
a minimum sufficient statistic (MSS) for estimating p is
∑N
i=1 yi. Therefore, with
respect to this model, no information is lost by collapsing missing outcomes into one
summary in each group. Therefore, g(Y Tmis) and g(Y
C
mis) can be represented by the
two axes of the enhanced TP display.
Figure 2.2 from Campbell et al. (2011) illustrates the initial idea of a tipping-point
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display described in Yan et al. (2009) for a binary outcome, where it results in a ma-
trix of all possible combinations of the number of successes among nonrespondents
in the treatment group and in the control group. Each combination is categorized
based on whether the corresponding missing pattern changes, or “tips”, the conclu-
sion about the estimated effect’s statistical significance. The staircase region marks
the tipping points of the study, i.e., the combinations of the number of successes
among nonrespondents in the treatment group (horizontal axes) and in the control
group (vertical axes) that alter the conclusion about the statistical significance of
the treatment effect, based on a chosen hypothesis test and a significance level. One
fundamental issue with this basic depiction is that the display has no information
about the likelihood of each individual combination. Therefore, unless we discover
that none of possible missing data patterns change the study’s conclusion, we cannot
utilize these displays to their fullest potential.
We use the initial idea of illustrating tipping points to propose a visual approach to
performing sensitivity analysis. It is done by introducing the following enhancements
to the displays:
• A colored heat-map that illustrates the gradual change of the quantity of inter-
est, e.g., the p-value from a hypothesis test used in the study. Moreover, it can
also represent the estimated treatment effects, τˆ , the lower or upper bounds of
confidence interval, or any other quantity that depends on a particular com-
bination of the number of successes among nonrespondents in the treatment
group and in the control group.
• Ticks, which represent historical estimates of the number of successes in each
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group, if such are available. For example, if axes represent the number of adverse
events among treated and among control subjects, the ticks could indicate the
numbers that correspond to the rates observed in previous studies for patients
with similar demographics and medical condition.
• The results from the current modeling procedure, e.g., the posterior draws of
Y mis under the chosen model f(Y ,D | T ,X ;θ,φ).
• Most important, the posterior draws of Y mis obtained under models with al-
ternative assumptions utilized for the sensitivity analysis. We elaborate on the
last two enhancements in the following sections.
The merit of adding ticks that correspond to historical and observed values is espe-
cially apparent because the practitioner may compare them with the values obtained
under the primary and alternative models and, based on that, judge the sensibility
of underlying assumptions.
As already mentioned, there are several quantities that may be of interest to a
practitioner and could be represented by a heat-map on a TP display. First, it can
represent the estimate of τ , as it varies depending on the number of successes among
missing outcomes. The relationship may be expressed as follows:
τˆ =
y¯TobsN
T
obs + y¯
T
misN
T
mis
NT
− y¯
C
obsN
C
obs + y¯
C
misN
C
mis
NC
(2.2)
=
y¯TobsN
T
obs + g(Y
T
mis)
NT
− y¯
C
obsN
C
obs + g(Y
C
mis)
NC
.
Another quantity of interest is the p-value that corresponds to a test of the estimated
treatment effect τˆ . Next, we illustrate the use of enhanced TP (or ETP) displays on
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a simulated example with a binary outcome and several fully-observed predictors.
2.3.1 Simulated Example with a Binary Outcome
In order to illustrate the use of ETP displays with a binary outcome, we gen-
erated data for N = 100 subjects with two predictors, representing sex, Female =
(female1, . . . , femaleN)
′, and age in years, Age = (age1, . . . , ageN)′, a treatment in-
dicator T = (t1, . . . , tN)
′, and a partially missing outcome Y = (y1, . . . , yN)′ (adverse
event occurrence). Predictor Female was simulated from Bern(0.5), and predictor
Age was simulated uniformly between 18 and 55 (rounding to the nearest integer).
The following models were used to generate the outcomes and the missingness,
logit(pi) =2ti − 0.001agei − 0.1femalei (2.3a)
− 0.05femalei · agei · I(agei > 35)
− 0.001femalei · age2i · I(agei > 35),
yi | pi ∼Binom(pi), (2.3b)
logit(ei) =3− 0.1agei − 0.5femalei + 0.5yi, (2.3c)
di | ei ∼Binom(ei), i = 1, . . . , N, (2.3d)
where I(·) is an indicator function. According to the notation introduced in Section
2.1, here XY D = (T ,Age,Female), while XY and XD are empty. As evident from
(2.3c), the missingness mechanism is MNAR. The model for pi (2.3a), the probability
of success for subject i, indicates that, although the treatment effect is positive, the
success rates decline steeply for females over 35. The rapid increase in the risk of
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adverse events after reaching a certain age is not an uncommon phenomenon, e.g.,
the risk of heart disease increases for men after the age of 45 and for women after the
age of 55, the risk of having fertility issues (miscarriage, birth defects, etc.) increase
sharply for women over 35.
In the simulated data, out of 100 subjects, NT = 40 were randomly assigned to the
treatment group and NC = 60 to the control group, with NTmis = 15 and N
C
mis = 21
subjects missing the outcome in each group, respectively. Figure 2.3 shows the heat-
map of τˆ for the generated data set, calculated according to (2.2). If we perform
the hypothesis test for the difference in proportions of successes between treatment
group and control group, the results may also be shown on the ETP display. Figure
2.4 shows the heat-map of p-values and outlines the region that corresponds to a
significant treatment effect based on the significance level of 0.05. Hence, the outer
contour of the region indicates the tipping points of the study, i.e., the number of
successes among missing outcome values in treatment group and control group that
would change the conclusion of the study e.g., {1,0},{2,0},{2,1} etc. Undoubtedly,
the best possible scenario for a researcher would be when the display shows no tipping
points, i.e., when all combinations of missing outcomes lead to the same conclusion
of the study. If it is not the case, as in our simulated example, then performing
sensitivity analysis can be critical, and ETP displays can be used to guide it.
Next, we illustrate the results of three analyses performed on the simulated data.
The first analysis assumes MCAR model and multiply imputes the missing out-
comes based on the rates of adverse events observed among respondents, without
taking into account available predictors. The last two analyses assume a MAR
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Figure 2.3: ETP display for the simulated binary outcome Y , showing the estimated
treatment effects using a heat-map. Axes represent the number of successes that
could be observed among nonrespondents in the treatment group and in the control
group. Each combination corresponds to a value of the estimated treatment effect τˆ
according to (2.2). Its magnitude and sign are represented using a color palette that
changes from dark blue (large negative value) to dark orange (large positive values),
with white representing zero estimated effect. Note that displaying each individual
value is optional (and, in fact, largely redundant), so we omit it in further displays.
The axes indicate that there were 15 missing outcomes among treated subjects and
21 among control subjects. Vertical and horizontal dashed lines (in blue) correspond
to observed success rate among treated and control subjects, 0.48 and 0.21.
mechanism, and multiply impute missing values from their approximate posterior
predictive distributions, obtained using MICE algorithm. The second analysis uses
a na¨ıve linear model for the log-odds of success to impute missing responses, i.e,
logit(pi | ti, agei, femalei;θ) = θ0 + θ1ti + θ2agei + θ3femalei. The third analysis
35
Chapter 2: Sensitivity Analysis for Partially Missing Binary Outcomes in a Clinical
Trial with Two Arms
Figure 2.4: ETP display for the simulated binary outcome Y , showing the p-values
from a chosen hypothesis test (i.e., test of the difference in proportions of successes
in treated and control groups). The heat-map represents p-values obtained from
the test conducted for each combination of the number of successes among treated
and among control subjects. The red grid highlights combinations that result in
a significant treatment effect at the 0.05 significance level, with a stair-case region
indicating the tipping points of the study.
includes all the relevant interactions, as specified in (2.3a) and, therefore, is more
accurate. Note that the actual details of the imputation procedure are not essential,
as long as a the procedure is proper and it uses plausible assumptions about the
missingness mechanism.
Table 2.1 gives the estimate of the treatment effect for the full data set. It also
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Table 2.1: Treatment effect on the outcome Y , estimated for the full dataset as well as
for the observed dataset, with missing values multiply imputed using three models.
For the na¨ıve and the complete models we assume MAR missingness. The results
from 100 MIs are combined for each model using Rubin’s rule.
Analysis Estimated difference 95% Interval
Full data 0.27 (0.09, 0.46)
MCAR 0.27 (0.05, 0.48)
Na¨ıve model 0.24 (-0.04, 0.53)
Complete model 0.31 (0.05, 0.57)
gives the estimates and corresponding 95% credible intervals obtained from 100 MIs
generated for each of the three analyses and combined using the Rubin’s rule (Ru-
bin 1987; Barnard and Rubin 1999). Figures 2.5 and 2.6 show the results of the MI
procedures, demonstrating different ways that the joint posterior distribution of the
missing values can be summarized1. Brown, blue, and red rectangles are drawn by
connecting minimum and maximum values among the imputations in each group un-
der the na¨ıve, complete, and MCAR models, respectively. In Figure 2.6, the (jittered)
points indicate actual imputed values for each model. The corresponding contours en-
circle 95% of points for each model, obtained by excluding 5% of points that have the
largest Mahalanobis distance from the sample mean. These contours approximates
the 95% posterior region of the joint distribution of successes among nonrespondents
in the treatment group and the control group.
We also added several vertical and horizontal ticks, showing counts that corre-
spond to hypothetical historical data. For example, if rates of success for subjects
with similar demographics were observed to be 0.35 and 0.60 in previous studies
of similar treatments, for our example they would correspond to having 2 and 12
1The R-procedure that constructs ETP displays for generated MIs can be downloaded from
http://sites.google.com/site/vliublinska/research.
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Figure 2.5: ETP display showing results from three MI procedures for the simulated
binary outcome Y . As before, the red grid highlights combinations that correspond to
a significant treatment effect based on a hypothesis test for the difference between two
proportions, using 0.05 significance level. In this simple version of the ETP display,
the rectangles indicate minimum and maximum values among 100 imputed numbers
of successes for nonrespondents in the treatment group and the control group under
the na¨ıve (brown), the complete (blue), and the MCAR (red) models. Also, the
display shows two vertical and two horizontal ticks (in purple), representing counts
that correspond to success rates {0.35, 0.60} for the treated, and {0.15, 0.34} for the
controls, serving to illustrate the use of data possibly available from previous studies.
This version of the ETP display (with heat-map showing p-values instead of treatment
effects) is used in the real-data example in Section 2.3.2.
successes among nonrespondents in the treatment group, respectively.
Figures 2.5 and 2.6 reveal a difference between counts imputed using the three
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Figure 2.6: ETP display, similar to the one shown in Figure 2.5, but more detailed.
The jittered points indicate the number of imputed successes for nonrespondents in
the treatment group and the control group under the na¨ıve (brown), the complete
(blue), and the MCAR (red) models. Brown, blue, and red contours contain 95% of
the imputations, while 5% of points with the largest Mahalanobis distance from the
sample average are excluded. The contours approximate the 95% posterior region of
the joint distribution of the number of successes among nonrespondents in the treated
group and the control group. The results obtained from the models are somewhat
different, indicating that both na¨ıve and MCAR models may not be accurate.
models. In addition, Table 2.1 shows that the three models produce conflicting con-
clusions regarding the significance of the effect, with the na¨ıve one indicating that
there is no significant treatment effect. If additional predictors in the complete model
were not relevant, we would expect similar results to be produced under both models.
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Next we describe how a systematic sensitivity analysis was performed on a real data
from a medical device clinical trial with multiple binary outcomes and substantial
missingness, and how ETP displays were utilized to summarize it.
2.3.2 Real-data Example
So far we focused on the situation with missing values confined to a single outcome.
However, the example that we present next involves a more complex problem and
demonstrates how the TP analysis can be extended to the situation with missingness
in more then one outcome. The data set that we use comes from a clinical trial
conducted in 2008-2009 in Germany. The objective of the study was to compare the
efficacy and safety of a new device for kyphoplasty, a novel treatment of vertebral
compression fractures, which are the most common complications of osteoporosis, to
the efficacy and safety of a traditional procedure, i.e., vertebroplasty. Both procedures
involve the injection of bone cement into fractured vertebrae, with the goal to relieve
pain caused by their compression and to prevent further damage.
A randomized prospective open-label study took place in four health centers across
Germany. The inclusion criteria for patients required, among other things, to have
up to three vertebral compression fractures in a specific region of their spines, to be
at least 50 years old, and to have pain levels above a certain threshold. A total of
84 subjects were evaluated, qualified, consented and randomized to one of the two
procedures, yielding 56 subjects assigned to the kyphoplasty (“treatment” group) and
28 to the vertebroplasty (“control” group).
A primary endpoint of the study was the number of cement leaks into the spinal
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canal, a potentially extremely serious complication that may lead to paraplegia. This
endpoint, as well as the pain score, were collected 24 hours after the surgery, while
the patients were still in the hospital. Both variables did not have any missing data,
therefore, we will not focus on them in this section. However, a randomization-
based analysis of these endpoints were highly supportive of the superiority of the
kyphoplasty procedure, performed using the new device.
The study also had several secondary endpoints, including the occurrence of vari-
ous adverse events within 3 months and between 3 and 12 months after the procedure,
that assessed the relative safety of the new device. The following six types of adverse
events were studied:
• adjacent level vertebral fracture (symptomatic and asymptomatic),
• distant level vertebral fracture (symptomatic and asymptomatic),
• retreatment (including refracture),
• death (12-month observations include deaths within 3 months).
In addition, subjects’ pain levels (0 through 10) and disability scores (0 through
100, assigned based on a completed questionnaire) were recorded during the 3- and
12-months follow-up appointments. Table 2.2 summarizes all secondary endpoints
collected in the study. In addition, a set of baseline measurements was collected for
each randomized patient, including:
• the number of vertebral compression fractures that required treatment (1, 2 or
3),
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Table 2.2: Secondary endpoints collected in the study, indicated by “+”.
Secondary Endpoint
Time after surgery
At 24h 1 day to 3 months 3 to 12 months
Occurrence of each of the six
adverse events
+ +
Pain level (0-10) + + +
Disability score (0-100) + +
• demographic and health data (age, sex, height, weight, BMI, physical activity
level, smoking status),
• baseline pain and disability scores, duration of symptoms, health center of stay,
presence of concomitant disease(s).
A considerable fraction of subjects were missing secondary endpoints. Table 2.3
reports percents of subjects in each group that had missing outcomes at each time-
point. Also, the occurrence of adverse events was rare, with the range of observed
rates between 0% and 2.6%, with the exception of deaths that were reported at 10.4%
rate during the 12-months follow-up; the patients’ age range at the baseline was 50 to
93, therefore such a high death rate was not surprising. However, death is considered
to be unrelated to the treatment assigned. In addition, a few subjects had missing-
ness in one or more of the baseline covariates. In summary, the study had several
major issues that complicated the analysis and required thorough attention: consid-
erable fraction of non-monotone missing data in secondary outcomes that were rarely
occurring events, some missingness in covariates and, moreover, small sample sizes
in the treatment and the control groups. Therefore, regardless of what assumptions
about the missingness we used for the initial analysis, it was essential to perform a
thorough sensitivity check to these assumption, and ETP displays were utilized for
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Table 2.3: Percent of subjects missing all secondary endpoints at each time-point.
Treatment group
Follow-up time-point
3 months, % 12 months, % 3 & 12 months, %
Kyphoplasty (NT = 49)† 24 43 18
Vertebroplasty (NC = 28) 18 36 11
†7 subjects were excluded from the treatment group after randomization due to
issues unrelated to the actual procedure.
(a) Continuous variables (b) Discrete variables
Figure 2.7: Love plots to check the balance between the treatment group and the
control group produced by the randomization.
this purpose.
We start with assessing the randomization procedure and making sure it produced
an acceptable balance between the treatment group and the control group. Figure 2.7
contains two “Love plots”, described in Section 1.3.2 (Ahmed et al. 2006), that show
standardized differences between average values of baseline measurements, or between
proportions for binary measurements, observed in each group. The two plots indicate
an excellent balance across the two groups. We proceed with multiply imputing
few missing values in baseline covariates. For that, we combine the two groups, as
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justified by the randomization, but remove the outcome data. We assume MAR
missingness in baseline measurements and apply the MICE algorithm to produce 100
complete data sets that will be utilized in subsequent analyses. Next, we describe the
adopted assumptions about the missingness mechanism for the secondary endpoints,
the procedure used for estimating the treatment effect, and the obtained results.
Questions of interest that concern secondary endpoints are whether the two treat-
ments differ in the rates of adverse events as well as in the post-treatment pain levels
and disability scores. As noted above, all secondary endpoints had large proportions
of missingness. Therefore, in order to perform the analysis, we have to consider plau-
sible assumptions about their missingness mechanism. For the initial analysis we
assume the MAR mechanism and proceed to multiply impute the missing secondary
outcomes using the MICE algorithm, taking into account available baseline covari-
ates. For that, the outcome data collected post-operatively are split into treatment
group and control group. Two analysts are assigned to perform multiple imputation
procedure on each part separately; both are blinded to each other’s outcome data.
This is done to limit the opportunity to bias the results, e.g., systematically impute
better values for subjects in the treatment group, as well as to allow different response
functions for the effects of each of the two treatments.
The sparsity of rare adverse events requires a special method of conditional im-
putation because it is not feasible to model the occurrence of each of the twelve
adverse events (six types observed at two time-points) individually. Instead, we use
a hot-deck approach by adopting a file-concatenation matching method introduced
in Rubin (1986), where each subject with missing secondary outcomes (i.e, a non-
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respondent) is matched based on available characteristics to a donor from a pool of
respondents, and the entire set of outcomes from the found donor is used to impute
missing outcomes for that nonrespondent. In addition, post-treatment pain scores
and disability indexes collected during the 3- and 12-months follow-up appointments
cannot be modeled as continuous variables due to small sample sizes and irregular
distributions of the observed values. Therefore, for the purpose of multiple imputa-
tion, we employ predictive mean matching (PMM, Rubin 1986; Little 1988a), another
hot-deck-type method that fits a linear model to observed responses and uses it to
match each nonrespondent with respondents by comparing their predicted responses.
In order to test whether or not the treatment group and control group showed
similar results in secondary outcomes, we employ a one-sided Fisher randomization
test. Table 2.4 reports results obtained from 100 complete data sets, combined using
Rubin’s rule, as described in Licht (2010). The results support the conclusion that
there is essentially no evidence that kyphoplasty, performed using the new device,
is worse than vertebroplasty in the rate of any adverse event, as well as in average
post-treatment pain scores or disability indexes. Next, we subject these conclusions
to a thorough sensitivity assessment.
The unassessable MAR assumption that underlies the imputation model for miss-
ing secondary endpoints raises concerns due to the large fraction of missingness. As
noted above, the imputation methods were hot-deck, i.e., using observed outcomes
from respondent donors. Hence, an implicit assumption of such methods is that each
nonrespondent resembles one or more of the respondents. However, further analy-
sis revealed that there was some nonoverlap in the values of baseline measurements
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Table 2.4: One-sided p-values from a Fisher randomization test for null-hypotheses
of no difference between the treatment group and the control group in the rate of
each of the adverse events. A one-sided alternative hypothesis was used to make it
possible to combine p-values from 100 complete data sets (see Licht 2010). Note that
none of the p-values provide any evidence against the corresponding null-hypotheses.
Alternative Hypothesis Treated subjects have fewer adverse events
Adverse events With 3 months Between 3 and 12 months
Retreatment 1.00 1.00
Symptomatic Adjacent Fracture 0.30 1.00
Symptomatic Distant Fracture 0.99 0.27
Asymptomatic Adjacent Fracture 1.00 0.99
Asymptomatic Distant Fracture 1.00 0.48
Death 0.13 0.59
Any event before 3 months 0.29 0.32
Pain score 0.66 0.29
Disability index 0.26 0.19
Alternative Hypothesis Treated subjects have more adverse events
Adverse events With 3 months Between 3 and 12 months
Retreatment 0.39 0.99
Symptomatic Adjacent Fracture 0.89 0.46
Symptomatic Distant Fracture 0.38 0.99
Asymptomatic Adjacent Fracture 1.00 1.00
Asymptomatic Distant Fracture 1.00 0.90
Death 0.99 0.68
Any event before 3 months 0.83 0.80
Pain score 0.34 0.71
Disability index 0.75 0.82
between respondents and nonrespondents in the control group (see Section 1.3.2).
Specifically,
• At 3-months follow-up:
– All three male nonrespondents were older than the oldest male respondent
(76, 77, 83 vs. 69 years old at the beginning of the study);
– Two out of three male nonrespondents had lower BMI than the lowest
observed BMI among respondents (21.5, 20 vs. 23.5);
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– One out of two female nonrespondents had prior smoking experience, and
no female respondent had it;
– One male nonrespondent had a longer hospital stay duration than all male
respondents.
• At 12-months follow-up:
– Two female nonrespondents were older than the oldest female respondent
(88, 89 vs. 85);
– One male nonrespondent was older than the oldest male respondent (83
vs. 77).
Note that the nonrespondents that did not resemble any respondents in the con-
trol group appeared to be in a poorer health than the respondents, e.g., older, with
higher BMI etc. Consequently, by using responses from healthier subjects in the con-
trol group to impute missing outcomes for nonrespondents, the hot-deck imputation
procedure produces results favoring the control group. Nevertheless, the detection
of nonoverlap provided us with a direction for constructing MNAR models: iden-
tify specific characteristic of nonrespondents that are outside of the range observed
among respondents and modify the odds of adverse events for subjects with these
characteristics, taking the odds estimated under the MAR model as a baseline,
logit{P (yi = 1 | di = 1, ti,xi , θ)} =
logit{P (yi = 1 | di = 0, ti,xi , θ)}+ δ(ti,xi), i = 1, . . . , N.
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The following eight characteristics were selected for the purpose of the sensitivity
analysis: males older than 69, males with BMI lower than 23.5, females with prior
smoking experience, males with duration of hospital stay longer than 2 days, females
older than 85, males older than 77, patients dead at 3 months, patients dead at 12
months. The odds of adverse events were imputed to be 50% higher (δ = ln(1.5))
or 50% lower (δ = ln(0.5)) than implied by the MAR model for the treatment group
or the control group separately. A total of 32 alternative models were fitted (eight
characteristics for two groups and two odds adjustments) and 100 MIs were produced
for each of them. Similarly to the simulated example on Figure 2.5, Figure 2.8 shows
the resulting ETP displays with rectangles indicating ranges of the number of adverse
events imputed under the initial model with the MAR assumption (dark blue) as
well as under each of the 32 alternative models. The heat-map represents p-values
from a one-sided Fisher randomization test, and the tipping-points of the study are
highlighted by a red contour. Historical values obtained from experts are marked on
each axes.
It is evident from the displays that the study conclusion is robust to all alterna-
tive models explored, because none of the rectangular areas covered the tipping-point
contour. These ETP displays reassure that there is little evidence for the differences
in safety between the new kyphoplasty device and the traditional vertebroplasty pro-
cedure. Considering that analysis of the primary endpoints showed significant benefit
of the new device, our TP analysis and displays helped advance the approval of the
device by the FDA.
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(a)
Figure 2.8: ETP displays for the twelve adverse events in the clinical trial described
in Section 2.3.2, with (jittered) rectangles showing ranges of the number of successes
for nonrespondents in treatment group and control group, imputed under the MAR
assumption (thick blue rectangle) as well as under each of the 32 alternative models
chosen for the sensitivity analysis. A vast majority of the models lead to the same
conclusion of no difference in the rate of adverse events between the treatment group
and the control group. Only a couple of models for the adjacent symptomatic fractures
(Figure 2.8i) produced borderline imputations.
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(b)
Figure 2.8: Continued.
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(c)
Figure 2.8: Continued.
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(d)
Figure 2.8: Continued.
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(e)
Figure 2.8: Continued.
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(f)
Figure 2.8: Continued.
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(g)
Figure 2.8: Continued.
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(h)
Figure 2.8: Continued.
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(i)
Figure 2.8: Continued.
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(j)
Figure 2.8: Continued.
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(k)
Figure 2.8: Continued.
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(l)
Figure 2.8: Continued.
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2.4 Discussion
In this chapter we proposed a systematic way to perform sensitivity analyses in
studies with binary outcomes, that are partially missing, using enhanced TP displays.
The displays facilitate the assessment of the strength of study’s conclusions under
the adopted assumptions and inform us about the effect of alternative models on the
conclusions. They systematize sensitivity analyses by taking advantage of modern
computing to create MIs under the current and alternative models, and to display
results using modern graphics.
Often, when assessing the impact of missing data on the study’s conclusion, re-
searches focus on the worst-case scenario, i.e., treated subjects with missing outcomes
are assumed to have zero successes and, at the same time, missing outcomes for con-
trols are set to be all favorable. In fact, in the simulated example shown in Section
2.3, this scenario would reverse the sign of the treatment effect, as it is evident from
Figures 2.4 and 2.6. The advantage of the ETP displays is that they allow the as-
sessment of other intermediate combinations, which are usually more realistic than
the worst-case scenario. Moreover, the displays can help to convey the fact that the
worst-case scenario may be unachievable, even if alternative assumptions, including
MNAR, about missing data mechanism are employed.
In the real-data example in Section 2.3.2, we tackled several issues at once, includ-
ing substantial missingness in the outcomes and small sample sizes in treatment and
control groups. A thorough sensitivity check is a key step in this situation, exploring
plausible models with alternative assumptions about the nature of missingness mech-
anism, including MNAR. An intuitive way to explore MNAR models is to use the
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fitted outcome model under the MAR assumption as a baseline and introduce var-
ious modifications for the nonrespondents’ model, informed by experts in the field.
In addition, ETP displays themselves may suggest possible directions for alternative
models that may tip the study’s conclusions. This approach provides a new collection
of useful tools for the analysis of data sets plagued with missing values. In the next
chapter we generalize this idea to studies with other types of outcomes.
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Sensitivity Analysis using
Enhanced Tipping-Point Displays
for Studies with a Dichotomous
Treatment and Partially Missing
Outcomes.
3.1 Introduction
An assumption is considered unassessable if there is no statistical procedure that
can be applied to available data that would support the assumption, without adding
more restrictions. For example, the choice of prior distributions for a set of model
parameters, the assumption of unconfounded treatment mechanism in nonrandom-
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ized experiments, and the stable unit treatment value assumption (SUTVA) in causal
inference are often unassessable. As we saw in Chapter 2, another area of statistics
where unassessable assumptions are necessary is missing data modeling. It is rec-
ommended to perform sensitivity checks when drawing conclusions from data with
missing values, especially if important policy decisions are at stake (NRC-Panel 2010;
Burzykowski et al. 2010; CHMP 2010), thereby revealing how sensitive the conclusions
are to the assumptions about the missing data mechanism.
In Chapter 2 we proposed a visualization, an ETP display, that allows for intuitive
and systematic exploration of various MAR and MNAR assumptions, and assessment
of their influence on a study’s conclusions, for cases with a dichotomous treatment and
a binary outcome. Here, we generalize the proposed displays to cases with continuous
outcome(s), and provide a collection of distributions for which ETP displays can be
easily constructed. Also, we provide a way to systematize the sensitivity analysis by
introducing a set of sensitivity parameters that arise from a pattern-mixture factor-
ization of the outcome distribution. Finally, we demonstrate how ETP displays can
be utilized to guide the sensitivity analysis by suggesting directions of high sensitivity.
The rest of this chapter is organized as follows. Section 3.2 provides a general
framework for constructing ETP displays. It includes a simulation study that demon-
strates the use of ETP displays with a partially missing continuous outcome and
addresses some challenges that arise for this case. In Section 3.3 we define a set
of sensitivity parameters and demonstrate their use. We conclude the chapter with
a description of available software packages to construct ETP displays and perform
sensitivity analyses (Section 3.4) and a discussion. In addition, Appendix B.1 char-
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Table 3.1: Outcome subgroups based on the treatment assignment indicator ti and
the missingness indicator di.
ti
0 1
di
0 Y Cobs Y
T
obs Y obs
1 Y Cmis Y
T
mis Y mis
Y C Y T Y
acterizes a set of distributions for which ETP displays can be easily built.
3.2 General Framework for ETP Displays
As before, T = (t1, . . . , tN) is a vector of binary treatment indicators for N sub-
jects. Let Y = (y1, . . . , yN) be a vector of univariate outcomes (not necessarily binary)
with missing values denoted by the vector of missingness indicators D = (d1, . . . , dN).
As in Section 2.3, given T and D, the vector of outcomes Y can be partitioned into
four sets, Y Tobs,Y
T
mis,Y
C
obs, or Y
C
mis as shown in Table 3.1. Again, suppose a goal
of the study is to estimate some estimand τ , e.g., the average treatment effect, or
determine a significance level for a test of τ and provide a confidence interval for it.
The impact of missing values on the estimate can be illustrated by an ETP display
with horizontal and vertical axes representing a function (or a summary) g(·) of val-
ues of missing outcomes for treated and control groups, g(Y Tmis) and g(Y
C
mis). The
analyst may choose any summary of interest as long as it is easily interpretable for
the intended audience.
ETP display allows us to study some quantity of interest q(Y ,D,T ,X ) for each
combination of g(Y Tmis) and g(Y
C
mis). For example, q(·) could be an estimate of τ or a
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p-value from a hypothesis test (i.e., t-test, noninferiority test, Fisher’s randomization
test etc.) used in the study. In addition, two displays can illustrate upper and lower
bound of a confidence interval for the estimate of τ . Values of q(Y ,D,T ,X ) are
illustrated on the display’s background by a “heat-map”, i.e., a matrix of colors, where
the colors reflect the magnitude and the sign of q(Y ,D,T ,X ). The heat-map can be
drawn by partitioning both axes into small intervals and evaluating q(Y ,D,T ,X ) at
all possible combinations of g(Y Tmis) and g(Y
C
mis) within a reasonable range.
The quantity of interest q(Y ,D,T ,X ) has to be a function of a pair of summaries
{g(Y Tmis), g(Y Cmis)}, i.e., every pair of summaries should correspond to one value of
q(Y ,D,T ,X ), although this function can be many-to-one. Convenient choices for
such summaries are minimal sufficient statistics (MSS) for parameter τ . When the
MSS is multidimensional, we can use one component of interest, while keeping others
fixed (see Section 3.2.1). Appendix B.1 provides further discussion of this approach
and identifies a particular set of widely-used distributions, especially suited for ETP
displays, with one-dimensional MSS readily available.
As described in Section 2.3, some supplemental information can be added to
augment the sensitivity analyses. First, for any hypothesis test, the region with
tipping-points can be highlighted. Second, vertical and horizontal lines can represent
meaningful reference points for g(Y Tmis) and g(Y
C
mis). For example, if g(·) represents
the average outcome for nonrespondents, then lines can mark the average, minimum
and maximum values observed in the data. Third, tick on axes can represent his-
torical values of average outcomes, if available, for subjects with similar background
characteristics that underwent similar treatments.
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A final layer of the ETP display summarizes posterior probabilities of each of the
combinations {g(Y Tmis), g(Y Cmis)} under various models for f(Y ,D | X,T ,θ,φ). The
posterior distributions can be calculated explicitly or approximated by means of MI.
The joint distribution can be summarized on a display in several ways: contour lines,
(1−α)100% credible regions (Held 2004), or probability regions, approximated using
Mahalanobis distance, as we illustrate in a simulated example in the next section.
3.2.1 Example with a Continuous Outcome
Consider a study with N subjects, randomly divided between treatment and con-
trol groups, treatment assignment vector T and outcome values Y . Suppose the
outcome is blood pressure, measured for each subject post-treatment. In addition,
two baseline fully-observed predictors are available: sex (XF , with “F” for female)
and years of school (XS, 0 through 21). Some subjects are missing the outcome, as
indicated by D, and our task is to estimate the marginal population treatment effect
on blood pressure and check its sensitivity to various assumptions about the missing
data.
Vector Y has four parts, described in Table 3.1. As in Section 2.3, we let τ be
the marginal average treatment effect, constant across all subjects, with its unbiased
estimator given by (2.1). Natural and easily interpretable summaries of missing out-
comes that can be used for axes of the ETP display in a continuous-outcome case
are average responses among nonrespondents in the treatment group and the control
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group,
g(Y Tmis) =
∑
i:yi∈Y Tmis
yi/N
T
mis = y¯
T
mis, g(Y
C
mis) =
∑
i:yi∈Y Cmis
yi/N
C
mis = y¯
C
mis.
Then, for a set of observed outcomes Y Tobs and Y
C
obs, τˆ can be represented as follows,
τˆ =
y¯TobsN
T
obs + g(Y
T
mis)N
T
mis
NT
− y¯
C
obsN
C
obs + g(Y
C
mis)N
C
mis
NC
. (3.1)
The continuous nature of the response makes it more challenging to generalize
ETP displays for this problem due to a wide variety of continuous distributions avail-
able for modeling Y . However, there are fundamental reasons for considering the
sample mean as a convenient statistic for this problem. When Y has a distribu-
tion that is a member of a natural exponential family of order one (NEF1, Morris
1982, 1983), it can be shown that sample mean is the MSS. Moreover, for certain
multiparameter exponential families, sample mean can also be a component of a mul-
tidimensional MSS. We describe a family of distributions that is particularly suitable
for ETP displays in Appendix B.1.
In order to illustrate the application of ETP displays to the case with continuous
outcomes, we use the following model to generate the data, independently for N units,
yi = 125 + 4ti + 0.3xi,S + xi,F + i, where
i | ti = 0 ∼ N(0, σ2C) and i | ti = 1 ∼ N(0, σ2T ),
di | pi ∼ Binom(pi), where
logit(pi) = 7− 0.6xi,S − ti + 0.0005yi, i = 1, . . . , N.
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Figure 3.1: ETP display for the continuous outcome, showing estimated average
treatment effects (3.1) using a heat-map. Horizontal and vertical axes represent aver-
age outcomes among nonrespondents in the treated and control groups, respectively.
Two pairs of vertical and horizontal blue lines correspond to minimum and maximum
values of outcomes observed in each group, and dashed blue lines represent average
outcomes, 134.1 and 131.3, for respondents in treated and control groups, respec-
tively. In addition, several horizontal and vertical ticks give historical values of the
average outcome for treated and control groups that may be available to the analyst.
Thus, each outcome yi is Normally distributed given xi,S, xi,F , and ti, with dif-
ferent standard deviations for treated (σT = 15) and control (σC = 10) subjects.
Predictors xi,F were generated from a Bern(0.5), and predictors xi,S were generated
using a multinomial distribution to draw a number of years of school from 0, 1, . . . 21
according to a plausible vector of probabilities. Under the assumption that the pa-
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rameters are unknown in each group and that the covariates are fixed, the distribution
of yi, given ti, is an exponential family (EF), and the data has a two-dimensional MSS
in each treatment group, (
y¯T , σˆ2T
)
and
(
y¯C , σˆ2C
)
,
where σˆ2T and σˆ
2
C are sample variances of outcomes in the treatment group and the
control group, respectively. In the generated data, the outcomes were missing for 28%
of the control subjects and 21% of the treated subjects. Figure 3.1 shows a heat-map
of estimated treatment effects τˆ , calculated using (3.1), for the simulated data set.
In order to perform a hypothesis test of the null-hypothesis H0 : τ = 0, we can
use a Welch’s t-test. However, the test statistic for the Welch’s t-test,
y¯T − y¯C√
σˆ2T
NT
+
σˆ2C
NC
, (3.2)
depends on sample means and sample variances of all outcomes, including the missing
ones. Therefore, in order to represent the results of the test on the ETP display, we
need to make additional assumptions.
Theorem 3.2.1. Suppose y1, . . . , yK ∼ Norm(µ, σ2) with Kobs values observed and
Kmis values missing completely at random, K = Kmis + Kobs. Suppose that we also
know the sample average of missing values, y¯mis. Then the uniformly minimum-
variance unbiased estimator (UMVUEs) of µ and σ2 will be
µˆ =
Kobsy¯obs +Kmisy¯mis
K
and s2 =
(Kobs − 1)σˆ2obs + KobsKmisK (y¯obs − y¯mis)2
Kobs
, (3.3)
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where y¯obs, y¯mis are sample means of observed and missing values, and σˆ
2
obs is
the sample variance of the observed values. Also, µˆ|µ, σ2 ∼ Norm(µ, σ2/K) and
Kobss
2|σ2 ∼ σ2χ2Kobs.
Proof. It is easy to show that both estimators are unbiased, and, because they are
based on complete sufficient statistics, according to the Lehmann-Scheffe theorem,
they are UMVUEs. According to the Basu’s theorem, with respect to the parameter
µ, the complete sufficient statistic y¯obs and the ancillary statistic σˆ
2
obs are independent,
and both are also independent from y¯mis, because the missingness is MCAR. Sampling
distributions of µˆ and s2 are evident after we recognize that
y¯obs − y¯mis ∼ Norm
(
0, σ2
(
1
Kobs
+
1
Kmis
))
Theorem 3.2.1 provides a way to construct a pivot, analogous to (3.2).
Theorem 3.2.2. The approximate sampling distribution of
µˆT − µˆC√
s21
NT
+
s20
NC
, (3.4)
where µˆT and s21 are calculated according to (3.3) for the treated subjects, and µˆ
C
and s20 are calculated similarly for the controls, is a t-distribution with the following
degrees of freedom
ˆ˜f =
(s21/N
T + s20/N
C)2
(s21/N
T )2/NTobs + (s
2
0/N
C)2/NCobs
. (3.5)
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Figure 3.2: ETP display for a continuous outcome, displaying p-values from a two-
sided Welch’s t-test. For each combination of average outcomes for nonrespondents in
the treatment group and the control group, the test-statistic is calculated according
to (3.4). The red contour highlights tipping-points of the study, which correspond to
the 0.05 significance level, and the heat-map represents the magnitude of the p-values.
The proof, similar to the one in Welch (1938), is presented in Appendix B.2.
Figure 3.2 shows the heat-map of p-values, obtained form the derived Welch t-test,
with a tipping-point contour that corresponds to a significance level of 0.05.
Finally, we proceed with analyzing the data by multiply imputing missing values
and estimating the population treatment effect under MCAR and MAR assumptions.
Figure 3.3 shows two convex hulls that contain 95% of average outcome values for
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Figure 3.3: ETP display with two convex hulls, each containing 95% of the 500
MIs, generated under the MCAR (yellow) and the MAR (orange) assumptions. The
excluded 5% of points have the largest Mahalanobis distance from the sample mean.
Background colors correspond to the estimates of the treatment effect, and red-shaded
region identifies combinations that would result in a “significant” treatment effect,
according to the derived two-sided Welch t-test, at the traditional 0.05 level. Note
that MAR and MCAR assumptions result in different sets of imputations, however,
neither of the two models give a clear answer to the question concerning a treatment
effect.
nonrespondents in treatment and control groups, produced by the MI procedure,
excluding 5% of imputations with the largest Mahalanobis distance from the sample
mean. The hulls approximate 95% posterior regions of joint distributions of average
outcomes among nonrespondents in the treatment and control groups under each
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Table 3.2: Treatment effect on Y , estimated under MAR and MCAR assumptions by
combining results from 500 MIs using Rubin’s rule.
MI assumption Estimated treatment effect 95% posterior interval
MCAR 2.6 (-0.85, 6.00)
MAR 2.8 (-0.60, 6.20)
model.
Note that neither of the two models produces conclusive results. Although, both
of them result in estimates of the treatment effect that are not significant (see Table
3.2), Figure 3.3 reveals how sensitive the results are to the assumptions about the
missingness mechanism. In the next section we propose a systematic way to formulate
alternative MAR and MNAR assumptions, and to utilize ETP displays to study the
sensitivity of the treatment effect estimate.
3.3 Exploring MNAR models with ETP displays
The majority of methods developed to handle missing data require MAR assump-
tion, and there is a shortage of standardized ways to explore alternative assumptions
systematically. Intuitively, there are two situations that violate MAR: (1) there ex-
ists an unobserved (or “lurking”) variable U that is an important predictor for both,
the partially-missing outcome and the missingness, or (2) the missingness mechanism
depends on the unobserved outcome itself. For example, suppose study subjects are
more likely to miss a follow-up appointment if they develop a complication after the
treatment, recorded by the variable U . At the same time, the outcome of interest
Y , e.g., subject’s pain level, also depends on whether any complication has occurred.
Therefore, failing to record U will result in the missingness that is not MAR. More-
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over, this situation also leads to the omission of the important predictor of Y from
the model f(Y | X,θ).
On the other hand, if we assume that all predictors that affect Y and D are
collected, then the only situation that leads to MNAR is when the missingness in Y
depends on unobserved values. In our example, this would mean that the pain level
itself made it more difficult for subjects to attend the follow-up appointment. An
important practical difference between the two situations described above is that the
first one can be avoided by careful study planning to anticipate the reasons for, and
minimize, dropouts (as recommended in NRC-Panel 2010, Ch.2-3), and the second
one can only be handled at the analysis stage, by modeling the missingness mechanism
explicitly and, thus, introducing more unassessable assumptions.
Recently, the NRC-Panel (2010) described a basic procedure that can be used to
systematize sensitivity analyses for experiments with missing data. The procedure
was based on the idea, originally proposed in Rubin (1977), of constructing the out-
come distribution for nonrespondents using the outcome distribution estimated for
respondents under the MAR assumption, but distorting it in a systematic manner.
Here we show how ETP displays can assist in a systematic exploration of alternative
distributions for the outcome. In particular, they can help identify deviations from
the MAR model along directions of high sensitivity, i.e., the types of models for the
nonrespondents’ outcomes in treatment and control groups that are likely to change
the study’s conclusions.
Suppose that the study units are independent and exchangeable. Parametric
inference for incomplete data with MNAR missingness requires specification of the
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joint distribution of the outcome and the missingness mechanism, f(y, d | x,θ,φ),
identical for all units. Two approaches to modeling MNAR mechanism data can be
used: selection models and pattern-mixture models. Selection models (Rubin 1974;
Heckman 1976) are based on the following factorization of the joint distribution,
f(y, d | x; θ˜, φ˜) = f(d | y,x; φ˜)f(y | x; θ˜),
with φ˜ and θ˜ a priori independent. This approach uses the idea of weighting
the marginal distribution of the outcome f(y | x; θ˜) by a selection probability,
f(d | y,x; φ˜), that accounts for a nonrandom nonresponse. Both parts of the fac-
torization have to be postulated, because there is no way to estimate either of them
empirically from data alone under the MNAR assumption.
Another approach called pattern-mixture models (Little 1994), first introduced
in Rubin (1977) and further pursued in Glynn et al. (1986), arises from a different
factorization,
f(y, d | x;θ,φ) = f(y | d,x;θ)f(d | x;φ) (3.6)
=
 f(y | d = 0,x;θ)P (d = 0 | x;φ) if d = 0,f(y | d = 1,x;θ)P (d = 1 | x;φ) if d = 1,
with φ and θ a priori independent. Under MAR, f(y | d = 0,x;θ) = f(y | d = 1,x;θ)
but, in general, the outcome models for respondents and nonrespondents may differ,
and the joint model for y and d is a mixture of the two models, f(y | d = 0,x;θ) and
f(y | d = 1,x;θ).
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An immediate benefit of the factorization in (3.6) is that two out of three compo-
nents, f(d | x;φ) and f(y | d = 0,x;θ), can be estimated from the observed data, and
the only part that requires unverifiable modeling assumptions is the conditional distri-
bution of the outcomes for nonrespondents, i.e., f(y | d = 1,x;θ). Another advantage
of pattern-mixture models is that they allow for a natural formulation (and inter-
pretation) of alternative models for the purpose of performing sensitivity analyses.
Because the outcome distributions for respondents and nonrespondents are specified
separately, alternative models for nonrespondents can be formed by introducing vari-
ous deviations to the model estimated for respondents. Moreover, the nature of these
deviations can be discussed with experts in the field. The two approaches, selection
and pattern-mixture modeling, are fundamentally related, as it is demonstrated in
Buuren (2012, Sec. 3.9.4) using Bayes Rule; also see extensive exchanges on this topic
by discussants in Wainer (1986).
Table 3.3 systematizes some types of modifications that can be used to model
anticipated differences between the distributions of outcomes for respondents and
nonrespondents when the outcome is continuous. Each row in Table 3.3 introduces a
new sensitivity parameter that can affect the study’s conclusion. Types 1 through 4
focus specifically on changes in the average outcome, types 5 and 6 modify the variance
of the outcome, and types 7 and 8 modify the entire distribution. These types may be
used one-by-one, as well as in any combination. For example, a family of modifications
that link the marginal response for respondents to the one for nonrespondents can
be represented by a set of sensitivity parameters {δ, βx1 , . . . , βxK , υ}. It implies that
the expected response for nonrespondents, E(y | x, d = 1, θ), is different from the
77
Chapter 3: Sensitivity Analysis using Enhanced Tipping-Point Displays for Studies
with a Dichotomous Treatment and Partially Missing Outcomes.
Table 3.3: Types of sensitivity parameters that can be introduced in order to link
the distribution of outcomes for respondents f(y | x, d = 0;θ) and nonrespondents
f(y | x, d = 1;θ) for a continuous outcome y. Here, χ is a proper subspace of the
covariate space, and x ∈ χ.
Type Modification Description
1 E(y | d = 1;θ) = E(y | d = 0;θ) + δ Marginal mean response
shift
2 E(y | x, d = 1;θ) = E(y | x, d = 0;θ) + δχ Conditional mean re-
sponse shift
3 E(y | d = 1;θ) = E(y | d = 0;θ) + βxjxj Marginal effect change
for xj
4 E(y | x, d = 1;θ) = E(y | x, d = 0;θ) + βχ,xjxj Conditional effect
change for xj
5 V ar(y | d = 1, θ) = υV ar(y | d = 0, θ) Marginal variance scal-
ing
6 V ar(y | x, d = 1, θ) = υχV ar(y | x, d = 0, θ) Conditional variance
scaling
7 f(y | d = 1;θ) = f(y/ω | d = 0;θ)/ω Response scale adjust-
ment
8 f(y | d = 1;θ) = f (g−1(y) | d = 0;θ)
∣∣∣ ddyg−1(y)∣∣∣ Response shape adjust-
ment, using the transfor-
mation g(·)
one that would have been observed if they were respondents with the same values of
covariates, E(y | x, d = 0, θ), by δ+ βx1x1 + · · ·+ βxKxK , and its variance is different
by υ. Analogously, conditional shifts, scaling or effect changes (types 2, 4 and 6)
are modifications that affect only specific subgroups of nonrespondents. They can be
introduced not only based on background characteristics, but also on the treatment
arm membership, e.g., mean outcome for respondents and nonrespondents can differ
by δt=0 for controls only, etc.
Parameters given in Table 3.3 suggest systematic ways to perform sensitivity anal-
yses for studies with missing data and, together with the ETP display, may reveal
models that exhibit especially high sensitivity. For example, the ETP display for
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the continuous case presented in Section 3.2.1 (Figure 3.3) suggests that models that
reduce mean outcome for nonrespondents in the control group or increase mean out-
come for nonrespondents in the treatment group, or both, can alter the conclusion
of the study that the treatment effect is insignificant at the 0.05 significance level,
reached under both MCAR and MAR models. The following modifications to the
MAR model, or their combinations, have these properties:
• E(y | d = 1, t, xF , xS, θ) = E(y | d = 0, t, xF , xS, θ) + δ;
• E(y | d = 1, t = 1, xF , xS, θ) = E(y | d = 0, t = 1, xF , xS, θ)+δt=1, with δt=1 > 0;
• E(y | d = 1, t = 0, xF , xS, θ) = E(y | d = 0, t = 0, xF , xS, θ)−δt=0, with δt=0 > 0;
• E(y | d = 1, t = 1, xF , xS, θ) = E(y | d = 0, t = 1, xF , xS, θ) + βt=1,xSxS, with
βt=1,xS > 0;
• E(y | d = 1, t = 0, xF , xS, θ) = E(y | d = 0, t = 0, xF , xS, θ) − βt=0,xSxS, with
βt=0,xS > 0;
• E(y | d = 1, t = 1, xF , xS, θ) = E(y | d = 0, t = 1, xF , xS, θ) + βt=1,xFxF , with
βt=1,xF > 0;
• E(y | d = 1, t = 0, xF , xS, θ) = E(y | d = 0, t = 0, xF , xS, θ) − βt=0,xFxF , with
βt=0,xF > 0.
After identifying combinations of parameters δ, δt=0, δt=1, βt=0,xS , βt=1,xS , βt=0,xF ,
and βt=1,XF that change the study’s conclusion, the analyst may defer to experts for
deciding whether any of these combinations represent plausible alternative models.
Figure 3.4 shows ETP displays with four contours that contain 95% of imputed means
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Figure 3.4: ETP display for the continuous outcome introduced in Section 3.2.1, with
convex hulls that include 95% of MIs produced under four alternative MNAR models
described in Table 3.4. The corresponding colors are 1-pink, 2-purple, 3-green, and 4-
yellow. The orange hull includes MIs produced under the MAR model, used in Section
3.2.1. The individual imputations are not displayed. All four contours for alternative
models are located in directions of high sensitivity from the contour obtained under
the MAR assumption.
for nonrespondents in treatment and control groups, produced using four alternative
MNAR models, along with the MIs obtained under the MAR model previously. Table
3.4 describes the models used and reports the estimated treatment effects under
each of them. All four models resulted in a “significant” treatment effect, estimated
closer to the true value. Therefore, if the changes introduced in any of these models
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Table 3.4: Average treatment effect on the continuous outcome Y , estimated under
four alternative MNAR models by combining 500 MIs produced under each model,
with true effect τ = 4.
Model
{δ, δt=0, δt=1, βt=0,xS ,
βt=1,xS , βt=0,xF , βt=1,xF }
Estimated average
treatment effect
95% posterior
interval
1 {−10, 0, 0, 0, 0, 0, 0} 3.91 (0.26, 7.56)
2 {0, 1, 4, 0, 0, 0, 0} 4.0 (0.57, 7.40)
3 {0, 0, 0,−6,−6,−0.5,−0.5} 3.99 (0.41, 7.57)
4 {−6.6, 0, 4.5, 5.2, 5.2, 0.14, 0.14} 3.91 (0.46, 7.36)
Table 3.5: Analogous to Table 3.3, types of sensitivity parameters that link distribu-
tions of a binary outcome y for respondents, f(y | x, d = 0;θ), and nonrespondents,
f(y | x, d = 1;θ).
Type Modification Description
1
logit(P{y = 1 | d = 1, θ}) =
logit(P{y = 1 | d = 0, θ}) + δ Marginal oddsscaling
2
logit(P{y = 1 | x, d = 1, θ}) =
logit(P{y = 1 | x, d = 0, θ}) + δχ
Conditional odds
scaling
3
logit(P{y = 1 | d = 1, θ}) =
logit(P{y = 1 | d = 0, θ}) + βxjxj
Marginal effect
change for xj
4
logit(P{y = 1 | x, d = 1, θ}) =
logit(P{y = 1 | x, d = 0, θ}) + βχ,xjxj
Conditional effect
change for xj
have firm scientific grounding, then the conclusion of no effect under MCAR and
MAR models should be carefully reviewed and, possibly, declared unreliable. This
result highlights the importance of sensitivity analyses, especially for studies with a
substantial fractions of missing outcomes and borderline conclusions.
Similar ideas can be applied to binary outcomes with slight differences in the in-
terpretation of sensitivity parameters. Table 3.5 defines some sensitivity parameters,
analogous to the ones in Table 3.3, for a binary outcome modeled using logistic link-
function. All sensitivity parameters affect the odds of success for nonrespondents. For
example, type 1 may be used if the odds of success for nonrespondents are believed
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to differ by a factor of eδ from the odds for respondents. The exploration of alter-
native models for binary outcomes can be done in the same manner as described for
continuous outcomes; see Section 2.3.2 for a real-data example with type 2 sensitivity
parameters.
3.4 Software for ETP Displays
There are several R-packages available to produce MIs under the MCAR or MAR
models1. Some of them use fully conditional specifications: mice, mi, BaBooN. Oth-
ers attempt to model the data jointly: amelia, MImix, mix, norm, pan. R-package
SensMice contains a function sens.mice (Resseguier et al. 2011) which allows users
to modify the imputation model, after it was estimated automatically under the MAR
assumption, for the purpose of performing sensitivity analysis. Available modifica-
tions are analogous to type 1 in Tables 3.3 and 3.5.
Among stand-alone software packages that perform multiple imputation are SO-
LAS 4.0, IVEware and WinMICE, which use chained equations, S-PLUS and NORM,
which model the data jointly. However, none of the existing versions of these pack-
ages offers any type of systematic sensitivity analyses. We have implemented an
R-procedure that draws ETP displays, as illustrated in this chapter, for generated
MIs. The procedure is available for download from http://sites.google.com/
site/vliublinska/research. Statistical Solutions Ltd are planning to implement
the sensitivity analysis capability, based on the ETP displays and the procedure de-
scribed in Section 3.3, into the SOLAS package.
1See http://www.stefvanbuuren.nl/mi/Software.html for a complete and up-to-date list
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3.5 Discussion
In this chapter we generalized a method of performing systematic sensitivity anal-
yses using ETP displays for studies with partially missing outcomes. As before,
the method requires a dichotomous treatment and a set of fully-observed predictors.
We showed that there is a substantial flexibility in the types of distributions of the
outcome that are suitable for the ETP displays. In addition to the family of one-
parameter NEF distributions, as well as any of their one-to-one transformations, we
demonstrated how the displays can be adapted to use with a two-parameter Normal
distribution of the outcome.
We also described an intuitive way to explore MNAR models by utilizing the
pattern-mixture factorization of the posterior distribution of the outcomes. Under
the MAR assumption, the distributions of the outcomes for respondents and nonre-
spondents, conditional on the same set of covariates, coincide, and the former can be
used as a baseline to construct many alternative models for the latter, by introducing
various sensitivity parameters. In fact, ETP displays themselves may suggest possi-
ble directions of high sensitivity for building alternative models that will change the
study’s conclusions.
There are many software packages that produce MIs for a data set with missing
values, e.g. SOLAS, IVEWare, MICE. We developed an R-procedure that draws ETP
displays using prespecified imputations. To summarize, the proposed displays help
reveal the weakness, or confirm the strength, of the conclusions of the study under
the adopted assumptions and guide the consideration of alternative models that can
alter the conclusions.
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Principal Stratification as a
Method of Sensitivity Analysis in
Studies with Missing Data
4.1 Introduction
In Chapters 2 and 3 we introduced enhanced tipping-point displays to help sys-
tematize the exploration of alternative models for data with missing values to assess
the strength of the drawn conclusions. Here we continue exploring methods of sensi-
tivity analyses and demonstrate the use of principal stratification framework for this
purpose.
Principal stratification (PS), first described by Frangakis and Rubin (2002), is a
general framework of adjusting the estimation of causal estimands based on post-
treatment outcomes. In its simplest form, this framework builds on the Rubin Causal
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Model (RCM, Holland 1986) by explicitly identifying latent classes (i.e., principal
strata) of units based on a categorization of all posttreatment outcomes. Potential
outcomes are then modeled separately for each principal stratum. Current applica-
tions of PS exist for several types of posttreatment outcomes, e.g., treatment noncom-
pliance (Imbens and Angrist 1994; Imbens and Rubin 1997), missingness in outcomes
(Jin and Rubin 2009), and censoring “due to death” (Zhang and Rubin 2003; Rubin
2006a; Zhang et al. 2008, 2009). All three of the complications above were recently
considered simultaneously in a study of causal effects of a job-training program on
employment and wages by Frumento et al. (2012)
Here we demonstrate a novel application of PS as a method of sensitivity analysis.
Several examples of the use of PS in the context of sensitivity analysis has been given
in the literature. Majority of them deal with one complication at a time, e.g., non-
compliance (Egleston et al. 2010), other intermediate outcome (Gilbert et al. 2003;
Hudgens et al. 2003; Shepherd et al. 2008), or censoring (Shepherd et al. 2007), and
handle a basic no-covariate settings. We also found an R-package sensitivityPStrat
that provides methods to perform sensitivity analyses of treatment effects within prin-
cipal strata described in some references mentioned above. The application presented
here handles two complications at once, which result in many more strata than in
existing examples. More importantly, our example incorporates covariates into the
outcome models, which substantially complicates the inference and requires an im-
proved method of model fitting introduced below.
Our application of PS is demonstrated on a clinical trial, described in Section
2.3.2, that had missingness in outcomes due to death. Recall that initial analysis of
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this trial was conducted under the assumption of no distinction between potential
outcomes missing due to death and outcomes missing due to other reasons (e.g., lost
to follow-up or missed appointments). However, as discussed by Rubin (1998, Section
6), Frangakis and Rubin (2002) and Zhang and Rubin (2003), such an assumption is
inappropriate, because potential outcomes for deceased subjects are not well-defined.
Undefined potential outcomes can arise in other settings, besides subject death
during the course of a study. For example, subject wages if unemployed, a miscarriage
for a women that is not pregnant, or a college graduate-point average (GPA) for high-
school drop-outs that did not get a General Equivalency Diploma are also undefined.
In these examples, “survival status” of a study subject (employment status, pregnancy
status, or drop-out indicator, correspondingly) is a posttreatment outcome, and is
crucial for defining and modeling potential outcomes of ultimate interest. As such,
we apply PS framework in our analysis to address the censoring due to death, and to
assess sensitivity of the study’s conclusions to alternative potential outcome model
specifications.
A second issue addressed in our application is the inherent difficulty of posterior
computations under PS. The current PS literature contains many analyses that em-
phasize the complex computations required for estimation of causal estimands (e.g.,
Barnard et al. 2003; Jin and Rubin 2009; Gallop et al. 2009; Zhang et al. 2009; Elliott
et al. 2010; Frumento et al. 2012). As a result of the fundamental problem of causal
inference, latent principal strata can never be fully observed, and can only be inferred
from background covariates and observed outcomes. Consequently, a model-based PS
analysis can involve weakly identified models, and the data may contain little infor-
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mation that helps characterize principal strata, or the sample size may not even be
sufficient for estimation purposes relative to the number of strata that are formed; all
these issues will slow down posterior computations.
The novelty of our approach lies in using Hamiltonian Monte Carlo algorithm,
originally called a Hybrid Monte Carlo (HMC, Duane et al. 1987), to obtain draws
from posterior distributions of interest. This algorithm can be viewed as a data-
augmentation (DA) strategy, because a vector of parameters, considered as a “posi-
tion” variable, is augmented with fully missing “momentum” vector, and Hamiltonian
dynamics are then used to perform a more effective exploration of the posterior. When
the gradient of the logarithm of the posterior exists, HMC can reduce the correla-
tion between successive draws considerably (Neal 1995) and converge faster than a
commonly used Metropolis-Hastings Monte Carlo (MHMC) method, even when the
support of the posterior has substantial curvature (Neal 2011). We demonstrate the
superiority of HMC over MHMC for posterior computations under the PS using data
from two real examples. Then we apply the HMC algorithm to the real data collected
from the medical device clinical trial and estimate various estimands of interest.
The rest of this chapter is organized as follows. In Section 4.2 we briefly summarize
the initial analyses performed for the clinical trial under consideration and describe
the issues not considered originally, especially the missingness due to death. In Section
4.3 we define principal strata, specify models for potential outcomes, and list the
attendant assumptions. Section 4.4 describes our HMC algorithm for PS, and includes
a comparison of the performance of HMC to that of a standard MHMC for two
examples, with further details provided in Appendices C.1, C.2 and C.3. Section 4.5
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describes results obtained for the clinical trial under consideration using HMC and
concludes with a discussion.
4.2 Description of the Clinical Trial
Our primary data comes from a noninferiority clinical trial described in Section
2.3.2. As it was noted, analysis of the primary outcome of interest, i.e. the fre-
quency of cement leakage, indicated that the new treatment resulted in significantly
fewer leaks. Then we focused on the secondary outcomes of interest, i.e., six ad-
verse events, posttreatment pain scores and disability levels, that had large fractions
of missing data, primarily as a result of missed follow-up appointments or patient
death. The initial analysis of secondary endpoints was performed under the MAR
assumption, ignoring the issue of censoring due to death. The resulting conclusion
was that the data provides no evidence for differences in rates of adverse events, aver-
age posttreatment pain scores, or disability levels between the treatment and control
groups.
We also demonstrated that there is essentially no sensitivity of this conclusion
to various deviations from the initial MAR assumption. We now perform a refined
sensitivity analysis, recognizing the fact that missingness due to death requires a
fundamentally different consideration. In the next section we provide a detailed
description of the application of PS to address this issue.
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4.3 Application of Principal Stratification to the
Clinical Trial
4.3.1 Notation and Identification of Principal Strata
The clinical trial under consideration had N = 77 subjects, including NT = 49
subjects that received the new treatment and NC = 28 that underwent a previously
approved procedure. Here we denote the vector of treatment assignment indicators
by Z = (z1, z2, . . . , zN)
′
, such that
zi =
 1 if subject i received the new treatment,0 otherwise,
i = 1, . . . , N . Let xi = (xi1, . . . , xiK)
′
be the vector of all pretreatment covariates for
subject i, and X = (x1, . . . ,xN) be a K ×N matrix of covariates for all subjects.
Several outcomes of interest were collected for each subject at two time points
after the surgery, three and twelve months. The first set of potential outcomes that
we consider is censoring due to death. For subject i at time point t ∈ {1, 2} under
treatment z ∈ {0, 1} a potential outcome di,t(z) is defined as
di,t(z) =
 1 if subject i is deceased at time t under treatment z,0 otherwise,
The value observed in the study is then
di,t = di,t(1)zi + di,t(0)(1− zi),
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Table 4.1: Principal strata generated by the censoring due to death. Of the total
number 24 = 16 of possible combinations, only nine distinct strata arise, because
death at time t = 1 automatically implies death at t = 2.
k di,1(1) di,2(1) di,1(0) di,2(0)
1 0 0 0 0
2 0 0 0 1
3 0 0 1 1
4 0 1 0 0
5 0 1 0 1
6 0 1 1 1
7 1 1 0 0
8 1 1 0 1
9 1 1 1 1
a function of the potential outcomes and observed treatment assignment. We let D1,
D2 be the observed vectors of death indicators, Dt = (d1,t, d2,t, . . . , dN,t)
′
.
Principal stratum for subject i are defined by the vector
si = (di,1(1), di,2(1), di,1(0), di,2(0))
′
.
For example, if subject i would be alive at 12 months after receiving a new treatment,
but would be deceased at 3 months follow-up if administered a control procedure, then
si = (0, 0, 1, 1)
′
. Alternatively, knowing the principal stratum of subject i immediately
determines the survival status under any treatment. Table 4.1 shows nine possible
strata that arise from different combinations of the survival status.
The second set of potential outcomes constitutes the main focus of our analysis.
For subject i at time point t under treatment z we define a vector of secondary
potential outcomes
y i,t(z) = (y1i,t(z), y2i,t(z), y3i,t(z))
′
,
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where y1i,t(z) represents a number of adverse events out of at total of five considered,
y2i,t(z) is the pain score (a number between 0 and 10, with 0 being no pain), and
y3i,t(z) is the disability index (a number between 0 and 100, with 0 indicating no
disability). We let Y t(z) be a 3 × N matrix of secondary potential outcomes for all
subjects, Y t(z) = (y1,t(z), y2,t(z), . . . , yN,t(z)). Note that if di,t(z) = 1, then y1i,t(z),
y2i,t(z), y3i,t(z) are all undefined.
Finally, we consider missingness in outcomes not due to death and define potential
outcomes that indicate missingness due to other reasons. Let
mi,t(z) =
 1 if all components of y i,t(z) are well-defined but missing,0 otherwise,
and let a vector M t(z) = (m1,t(z),m2,t(z), . . . ,mN,t(z))
′
contain missingness indi-
cators at time t under treatment z for all subjects in the study. Analogous to
principal strata that arise from the survival status, further principal stratification
can be introduced on the basis of potential missingness, with strata defined as
(mi,1(1),mi,2(1),mi,1(0),mi,2(0))
′
. A total of 16 strata are generated by this approach,
as summarized in Table 4.2.
However, such level of generalization introduces considerable challenges in the es-
timation of outcome models for each individual stratum, because it asserts that some
outcomes will never be observed, e.g., outcomes for subjects that belong to strata 15
and 16 in Table 4.2. Therefore, their models can not be estimated without substan-
tial unassessable assumptions. Moreover, the total number of possible strata, defined
both by survival status and potential missingness, is 9 · 16 = 144. Although this is
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Table 4.2: Principal strata generated by potential missingness in potential outcomes
due to other reasons besides death, observed at two time-points under the dichoto-
mous treatment.
j mi,1(1) mi,2(1) mi,1(0) mi,2(0)
1 0 0 0 0
2 0 0 0 1
3 0 0 1 0
. . . . . . . . . . . . . . .
15 1 1 1 0
16 1 1 1 1
theoretically the most complete specification of principal strata in the clinical trial
under consideration, the sample size of only N = 77 would make the analysis prac-
tically infeasible. Therefore, we do not consider the generalization due to potential
missingness and proceed with the analysis under the original MAR assumptions.
Table 4.3 summarizes our notation and provides an example of a “Science” (Rubin
2007) of the study,
(X,S,Z,M 1,M 2,D1(T ),D2(T ),D1(C),D2(C),Y 1(T ),Y 2(T ),Y 1(C),Y 2(C)) ,
a collection of all pretreatment covariates, treatment and stratum indicators, and
potential outcomes, for a particular realization of the treatment assignment. Next,
we list assumptions utilized in our analysis.
4.3.2 Assumptions and Estimands of Interest
The following assumptions are necessary for using PS framework:
• Stable Unit Treatment Value Assumption (SUTVA, Rubin 1980). Potential
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Table 4.3: The example of the Science for subjects in the study for a particular
realization of the treatment assignment. Note that di,t(z) and y i,t(z) are always
missing simultaneously.
i xi si zi di,1(1)di,2(1)di,1(0)di,2(0) y i,1(1)y i,2(1)y i,1(0)y i,2(0)
1 * ? 1 * * ? ? * * ? ?
2 * ? 1 * * ? ? * * ? ?
. . . * ? 1 * ?? ? ? * ?? ? ?
NT * ? 1 * * ? ? * * ? ?
NT + 1 * ? 0 ? ? ?? ?? ? ? ?? ??
NT + 2 * ? 0 ? ? * * ? ? * *
. . . * ? 0 ? ? ?? * ? ? ?? *
NT +NC * ? 0 ? ? * * ? ? * *
* indicates observed values, ? indicates unobserved values, ?? indicates missing values
not due to death.
outcomes of any specific subject do not depend on other subjects’ treatment
assignments, i.e., for any two vectors of treatment assignments Z,Z ′ ∈ {0, 1}N ,
with zi = z
′
i, SUTVA states that
y i,t(Z
′) = y i,t(Z ) and di,t(Z ′) = di,t(Z ), for t = 1, 2,
where yi,t(Z ) are di,t(Z ) are vectors of potential outcomes for unit i under
treatment assignment Z for all units in the study. SUTVA also requires that
there is only one well-defined version of each treatment (e.g., no dose variations).
Both conditions ensure that there are only two potential outcomes for each
subject at each time point, corresponding to the two possible treatments. There
are many plausible scenarios that would result in a violation of this assumption
in the trial. For example, there is no information about doctors that performed
the surgeries: if some doctors treated more than one patient, their technique
could have improved with time, and so potential outcomes of later patients
93
Chapter 4: Principal Stratification as a Method of Sensitivity Analysis in Studies
with Missing Data
would effectively have depended on the treatment assigned to subjects entering
the study earlier. Given lack of evidence that contradicts SUTVA, we make this
assumption in our analysis.
• Unconfoundness (Rubin 1990). Treatment assignment depends only on ob-
served pretreatment covariates:
Z | D1(0),D2(0),D1(1),D2(1),Y 1(0),Y 2(0),Y 1(1),Y 2(1),M 1,M 2,X ∼ Z | X.
Randomization performed in the trial justifies this assumption. By design, the
distribution of the treatment indicators Z is
f(Z | X ) = f(Z ) =
 1/
(
N
NT
)
if
∑
zi = NT ,
0 otherwise.
In fact, because 0 < P (zi = 1) < 1 for all i, the assignment mechanism is also
strongly ignorable (Rosenbaum and Rubin 1983).
• Ignorable missingness mechanism (Rubin 1976; Little and Rubin 2002). Miss-
ingness in outcomes is MAR, and parameters that govern the missingness and
potential outcomes models are distinct (see Section 1.1). Let M 1 and M 2 be
vectors of missingness indicators at three and twelve months after the surgery,
respectively, and let
f(M 1,M 2 | Y 1(1),Y 2(1),Y 1(0),Y 2(0),D1(1),D2(1),D1(0),D2(0),S,Z,X ;φ)
(4.1)
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be the conditional distribution of the missingness indicators, governed by the
vector-parameter φ, given the rest of the Science. Formally, ignorability implies
that (4.1) equals
f(M 1,M 2 | Y obs1 ,Y obs2 ,Dobs1 ,Dobs2 ,Z ,X ;φ),
where Y obs1 , Y
obs
2 , D
obs
1 , D
obs
2 are the observed outcome values and death indi-
cators at each time-point, respectively. Ignorability is unassessable, i.e., the
observed data themselves cannot confirm or contradict it without additional
assumptions. Ignorability is assumed in the trial under consideration to sim-
plify the analysis, however, this assumption can be relaxed by assuming latent
ignorability (Frangakis and Rubin 1999), where missingness is related to death.
Although latent ignorability may be more realistic, it would complicate compu-
tation and modeling considerably.
In Section 4.3.1 we identified nine principal strata that arise from the survival
status. We reduce the number of strata by making the following assumption.
• Monotonicity of the treatment effect on death (Zhang and Rubin 2003). Assign-
ment to the new treatment results in the same or better survival status than
assignment to the control, i.e. di,t(1) ≥ di,t(0), for t = 1, 2 and i = 1, . . . , N . As
shown in Table 4.4, this assumption reduces the number of strata from nine to
six. Under monotonicity, we redefine latent stratum indicators si as each taking
a value from the following set Ω = {aa, pa, pp, na, np, nn}.
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Table 4.4: Final set of strata that arise from having some outcomes censored due
to death and assuming monotonicity. Here, “a” stands for always-survivor, “p” for
partial survivor and “n” for never-survivor, and the position of the letter corresponds
to the time period.
k di,1(0) di,2(0) di,1(1) di,2(1) Stratum label
1 0 0 0 0 aa
2 0 1 0 0 pa
3 1 1 0 0 na
4 0 1 0 1 pp
5 1 1 0 1 np
6 1 1 1 1 nn
As discussed earlier, it is important to define latent strata based on survival sta-
tus because outcomes for diseased subjects are not well-defined. This fact limits
meaningful estimands to particular principal strata. Here, we focus on the following
finite-population estimands:
• Average treatment effects on the number of adverse events, pain score, and
disability index at 3 months for partial and always survivors,
δ1 =
N∑
i: si∈{aa,pa,pp}
{y i,1(1)− y i,1(0)}/
N∑
i: si∈{aa,pa,pp}
1.
Each component of this vector of estimands can also be viewed as a weighted
average of separate treatment effects for the three strata aa, pa, and pp.
• Average treatment effects on the number of adverse events, pain score, and
disability index at 12 months for always-survivors in both treatment groups,
δ2 =
N∑
i: si=aa
{y i,2(1)− y i,2(0)}/
N∑
i: si=aa
1.
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In addition, we are interested in the following descriptive estimands:
• Probability of death within 3 months under the treatment and under the control,
ξz1 =
N∑
i:zi=z
di,1(z)/
N∑
i:zi=z
1 =

∑N
i=1 I (si ∈ {na, np, nn}) /N if z = 0,∑N
i=1 I (si = nn) /N if z = 1.
• Chance of death between 3 and 12 months under the treatment and under the
control,
ξz2 =
N∑
i:zi=z
{di,2(z)− di,1(z)}/
N∑
i:zi=z
1 =

∑N
i=1 I (si ∈ {pa, pp}) /N if z = 0,∑N
i=1 I (si ∈ {np, pp}) /N if z = 1.
4.3.3 Model Specifications for Potential Outcomes and Prin-
cipal Strata Membership
Principal strata are usually only partially observed, however, we can identify a
set of strata that correspond to each combination of observed survival statuses for
subjects in the treatment or the control groups. Table 4.5 groups the observed data
in our study and lists the corresponding latent strata for each group.
We proceed with specifying a Bayesian model for the potential outcomes, sepa-
rately for each principal stratum. A full joint distribution of the potential outcomes
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Table 4.5: Observed subject groups, corresponding principal strata and the number
of subjects in each group. Here, ?? indicates missing values that could have been
observed.
Treatment group Observed outcomes
groups O(di,1, di,2)
Possible latent strata Number of sub-
jects (N = 77)
T O(0, 0) aa, pa, na 25
T O(0, 1) np, pp 3
T O(1, 1) nn 0
C O(0, 0) aa 17
C O(0, 1) pp, pa 1
C O(1, 1) na, np, nn 2
T O(0, ??) aa, pa, pp, na, np 9
T O(1, ??) nn 0
T O(??, 0) aa, pa, na 3
T O(??, 1) np, pp, nn 2
T O(??, ??) aa, pa, pp, na, np, nn 7
C O(0, ??) aa, pp, pa 5
C O(1, ??) aa, np, nn 0
C O(??, 0) aa 2
C O(??, 1) pa, pp, na, np, nn 0
C O(??, ??) aa, pa, pp, na, np, nn 1
can be partitioned as follows,
f(Y 1(C),Y 1(T ),Y 2(C),Y 2(T ),D1(C),D1(T ),D2(C),D2(T ),M 1,M 2,Z ,S | X ;θ,φ) =
f(Y 1(C),Y 1(T ),Y 2(C),Y 2(T ),Z ,S | X ;θ,φ)·
f(M 1,M 2 | Y 1(C),Y 1(T ),Y 2(C),Y 2(T ),D1(C),D1(T ),D2(C),D2(T ),Z ,X ;θ,φ) =
f(Z )f(Y 1(C),Y 1(T ),Y 2(C),Y 2(T ),S | Z,X ;θ)·
f(M 1,M 2 | Y obs1 ,Y obs2 ,Dobs1 ,Dobs2 ,Z ,X ;φ)
Last equality holds by the ignorability assumption and randomization. Because we are
interested in estimating θ only, we can drop the model for the missingness mechanism
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and consider the following part only,
f(Y 1(C),Y 1(T ),Y 2(C),Y 2(T ),S | Z,X ;θ). (4.2)
Principal stratum membership is modeled using multinomial distribution with
logistic link-function and four predictors xi1, . . . , xi4, corresponding to age, sex, the
interaction of age and sex, and BMI,
Pr(si = s | xi;ψ) = exp(ψs,0 + ψs,1xi1 + ψs,2xi2 + ψs,3xi3 + ψs,4xi4)∑
h∈Ω exp(ψh,0 + ψh,1xi1 + ψh,2xi2 + ψh,3xi3 + ψh,4xi4)
, (4.3)
where s ∈ Ω and ψ is a vector of all parameters. We let ψnn,0 = ψnn,1 = · · · = ψnn,4 =
0, so that stratum nn is taken as a baseline. Model (4.3) requires estimating 5 ·5 = 25
parameters and, in order to simplify it, we assume that the slopes that correspond to
each predictor are identical across principal strata: ψk ≡ ψs,k = ψs˜,k for all s, s˜ ∈ Ω
and for k = 1, 2, 3, 4. This restriction reduces the number of parameters to 4 + 5 = 9,
making the subsequent estimation more feasible.
Next, we introduce the model for the vector of potential outcomes y i,t(z) =
(y1i,t(z), y2i,t(z), y3i,t(z))
′
, z ∈ {0, 1} and t = 1, 2. Here, y1i,t(z) represents a num-
ber (0-5) of adverse events observed for unit i within 3 months (t = 1) or between 3
and 12 months (t = 2) after the surgery, if assigned to group z. Therefore, we use
Binomial distribution to model these outcomes, conditional on stratum si:
y1i,t(z) | si,xi,β ∼ Binom(qi,t(z), 5),
logit(qi,t(z)) = βsi,1tz,0 + βsi,1tz,1xi5 + βsi,1tz,2xi6, (4.4)
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where β is a vector of all parameters, and xi,5, xi,6 are baseline pain score and disability
index.
Last two outcomes of interest, y2i,t(z) and y3i,t(z), represent pain scores and dis-
ability indexes. In order to be eligible for the study, subjects were required to have
certain minimum pretreatment pain score and disability index, and a desirable out-
come of the surgery was to reduce both characteristics to zero. Both treatment and
control procedures in the study were very effective in reducing pain and disability
and, as a result, the distributions of these measures have a large point mass at zero
(see Figure 4.1).
For simplicity, we consider new outcomes that indicate whether pain and disability
were fully eliminated, y˜ri,t(z) = I(yri,t(z) = 0), and model them as follows:
y˜ri,t(z) | si,xi ,β ∼ Bern(uri,t(z)),
logit(uri,t(z)) = βsi,rtz,0 + βsi,rtz,1xi5 + βsi,rtz,2xi6. (4.5)
Note that all three outcomes, yri,t(z) with r = 1, 2, 3, are defined in the following
cases only:
• t = 1, z = 0 and subject i is in stratum si ∈ {aa, pa, pp},
• t = 1, z = 1 and subject i is in stratum si ∈ {aa, pa, na, pp, np},
• t = 2, z = 0 and subject i is in stratum si = aa,
• t = 2, z = 1 and subject i is in stratum si ∈ {aa, pa, na}.
Considering that y˜ri,t(z) can be correlated across strata and time, we use slopes to
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Figure 4.1: Histograms of pain scores and disability indexes, recorded at 3 and 12
months after the surgery. Note the point mass at zero for all four outcomes.
reflect this fact, by assuming that βk ≡ βs,rtz,k = βs˜,r˜t˜z˜,k for all r, r˜ = 1, 2, 3 and
k = 1, 2, 3, and combinations of (s, t, z), (s˜, t˜, z˜) ∈ Ω × {1, 2} × {0, 1} for which the
outcomes exist. In other words, the slopes for each predictor are the same across all
potential outcomes. This assumptions reduced the number of parameters for models
(4.4) and (4.5) from 3 × 3 × 12 = 108 to 3 × 12 + 2 = 38. To summarize, the total
number of parameters required to model (4.2) is 47 (see Appendix C.1). In the next
section we introduce HMC, the computational method used to perform model-fitting
and compare its performance to that of a standard MHMC.
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4.4 Application of HMC Method to PS Computa-
tions
4.4.1 General Overview
HMC method uses Markov Chain Monte Carlo (MCMC) technique to efficiently
sample from complex joint distributions with highly-correlated parameters using
Gibbs sampling, combined with the acceptance rule from MHMC method and
ideas from Hamiltonian dynamics. Suppose the goal is to sample θ ∈ <J from
pi(θ) ∝ exp{−U(θ)}. The HMC method considers an artificial dynamic system, view-
ing θ as position coordinates of a particle with potential pseudo-energy equal to U(θ).
In addition, it introduces auxiliary momentum vector p ∈ <J and defines a kinetic
pseudo-energy of the particle as k(p) = p′Λ−1p/2, where Λ is a J ×J positive-definite
“mass matrix” (e.g., if it is diagonal, its elements can be viewed as “masses” of each
component of θ).
MCMC sampling is performed on the augmented parameters space (θ,p) that has
the following distribution,
pi(θ,p) ∝ exp{−H(θ,p)},
where H(θ,p) = U(θ)+k(p). The function H(θ,p) is called Hamiltonian, it represents
the total energy of the particle. Marginally, it can be shown that θ ∼ pi(θ) and
p ∼ NormJ (0,Λ). Sampling rules are derived from the law of the conservation of
energy, that says that the total energy remains constant in a closed system. The
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advantage of this method is that the resulting MCMC moves follow the dynamics of
the target distribution more closely: produced proposal are distant and have high
probability of acceptance, which results in more efficient exploration of the target
distribution (Liu 2008, Ch. 9).
An important aspect of our HMC implementation is the choice of the mass matrix
Λ. As discussed in Girolami and Calderhead (2011), the efficiency of the algorithm
can be increased if the mass matrix reflects the curvature of the target distribution. At
the beginning of the Gibbs step that generates a draw from the conditional posterior
of θ, we first find the minimum of the negative logarithm of the posterior and evaluate
the Hessian of this function at the minimum. This choice of mass matrix for HMC
algorithm results in a converging Markov chain, with a stationary distribution that
is the desired posterior pi(θ), as justified by Theorem 1 in Burda and Maheu (2011).
As noted in Section 4.1, posterior computations under PS can be difficult to im-
plement, because principal strata are not necessarily fully observed for all subjects in
a study and have to be inferred from background covariates and observed outcomes.
Next we demonstrate the application of the HMC-within-Gibbs algorithm to calculat-
ing posterior distribution of estimands of interest with two examples that have simpler
data structures (two and three principal strata defined by non-compliance).We also
use these examples to compare the performance of our algorithm to that of a standard
MHMC algorithm.
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4.4.2 Example 1: Canvassing and Voter Turnout
For our first example we use a randomized factorial experiment performed by
Gerber and Green (2000, 2005) to study the effects of non-partisan mail, canvassing,
and phone calls on voter turnout. For illustration purposes, we focus on canvassing
only, and compare turnout behavior for subjects assigned to the canvassing treatment
against those assigned to no treatment. Further details of this analysis are given in
Gill et al. (2013).
The data consists of N = 6, 617 experimental subjects randomly assigned to
canvassing (zi = 1) or not (zi = 0). A subject assigned to be canvassed can refuse
to comply. Let di(z) indicate if subject i is actually canvassed under treatment z. If
di(z) = z, then a subject is said to be a complier, whereas if di(0) = di(1) = 0, then
a subject is said to be a never-taker. By design of the experiment, it is impossible for
a subject to be canvassed when assigned control, i.e., for di(0) = 1. Therefore, only
two principal strata are formed: compliers and never-takers, represented by si = c if
(di(0), di(1))
′
= (0, 1)
′
and si = n if (di(0), di(1))
′
= (0, 0)
′
, respectively.
Potential outcome yi(z) is defined as
yi(z) =
 1 if subject i voted in the election under treatment z,0 otherwise.
Estimands of interest are finite population average causal effects of canvassing for
never-takers and compliers, defined as
∑
i:si=n
{yi(1)− yi(0)} /
∑
i:si=n
1 and
∑
i:si=c
{yi(1)− yi(0)} /
∑
i:si=c
1. (4.6)
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Note that compliance status is unknown for subjects assigned control who are not
canvassed: these subjects form a mixture of compliers and never-takers. For each
individual in the study, K = 4 pretreatment covariates are available: age, party
affiliation (Democrat or Republican), abstention from the 1996 election (yes or no),
and voting in the 1996 election (yes or no), denoted as x1, . . . ,x4. All four covariates
are used to model strata membership and potential outcomes distributions, with
models similar to (4.3) and (4.4). The final vector of model parameters, θ = (ψ,β),
has 13 components. See Appendix C.2 for more details on models and computations.
We apply the HMC-within-Gibbs algorithm as well as a standard MHMC-within-
Gibbs algorithm to obtain draws form the posterior distribution of model parameters
θ and estimands (4.6), and compare their performance. The specific MHMC algorithm
considered is similar to the HMC sampler, with the exception that parameter draws
are obtained by a random walk Metropolis step instead of an HMC step, within the
overall Gibbs procedure. Also, the covariance matrix of the Normal proposal equals to
the matrix inverse of the Hessian of the negative logarithm of the current conditional
posterior.
We ran 10 independent chains of length 2000 with random initializations and
discarded a burn-in of 1000 draws. Table 4.6 summarizes diagnostic statistics, cal-
culated for the obtained draws, i.e., GR statistics (Gelman and Rubin 1992) and
effective sample sizes (ESS). It is evident from the table that the HMC algorithm is
superior to MHMC for this problem in all parameters, i.e., it produces GR statistics
that are closer to one and results in larger ESS. In addition, Figures 4.2 and 4.3 show
autocorrelation plots of draws generated using HMC and MHMC, respectively, for
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Table 4.6: Summary of diagnostics for HMC-within-Gibbs and MHMC-within-Gibbs
algorithms, applied to Example 1 described in Section 4.4.2. Here, piψ and piβ denote
log-posteriors for each set of parameters. Note that HMC outperformed MHMC on
all parameters under each setting.
HMC
Without Exclusion With Exclusion
Parameter GR ESS GR ESS
piψ 1.01 1724 1.01 1798
piβ 1.07 117 1.06 752
ITTC 1.21 80 1.02 644
ITTN 1.20 96 1.01 1865
MHMC
Without Exclusion With Exclusion
Parameters GR ESS GR ESS
piψ 1.13 211 1.12 184
piβ 2.53 72 1.42 123
ITTC 3.06 101 1.32 205
ITTN 2.68 169 1.09 1223
the case with exclusion restrictions. The gain in efficiency is apparent from the fact
that autocorrelations between consecutive and near-consecutive draws are generally
smaller for the HMC.
4.4.3 Example 2: Influenza Vaccination and Flu
For our second example we use data from a study of a causal effect of influenza
vaccination on flu-related hospitalization visits, described in Hirano et al. (2000).
The experiment consisted of sending letters to randomly chosen group of doctors,
encouraging them to inoculate their patients. However, a patient could choose to
ignore doctor’s encouragement to get a vaccination.
Let zi indicate whether the patient i was encouraged (zi = 1) or not (zi = 0).
Let di(z) indicate whether subject i received a flu vaccine under treatment z. There
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Figure 4.2: Autocorrelation plots of draws produced by HMC algorithm in Example
1, described in Section 4.4.2, for the case with exclusion restrictions. They show
relatively low autocorrelation between consecutive and near-consecutive draws.
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Figure 4.3: Autocorrelation plots of draws produced by MHMC algorithm in Example
1, described in Section 4.4.2, for the case with exclusion restrictions. As compared to
the plots in Figure 4.2, correlations between consecutive and near-consecutive draws
are much higher.
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are three principal strata in this experiment: compliers (di(z) = z), never-takers
(di(0) = di(1) = 0), and always-takers (di(0) = di(1) = 1), represented by si = c, n,
and a, respectively. Potential outcome yi(z) is defined as
yi(z) =
 1 if subject i had a flu-related hospitalization under treatment z,0 otherwise.
For a total N = 2, 891 experimental subjects, the notation and model setup are
similar to the example in Section 4.4.2, with the difference that only K = 2 pre-
treatment covariates are recorded for each subject: age, and an indicator for chronic
obstructive pulmonary disease. The goal is to estimate model parameters θ, 13 in
total, and three estimands of interest: finite population causal effects defined as in
(4.6) for each of three strata. Further details are outlined in Appendix C.3.
Once again, we compare the performance of our HMC-within-Gibbs algorithm to
that of a standard MHMC algorithm, and summarize the results in Table 4.7. HMC
outperforms MHMC in GR statistics for all parameters. However, comparison of ESS
indicates that, although in majority of settings and for most of the parameters HMC
has higher ESS, the results are not as consistent for the estimates of ITTA and ITTN .
Examples of autocorrelation plots are included in Appendix C.3.
4.5 Results and Discussion
We apply HMC-within-Gibbs algorithm to the data from a clinical trial under
consideration to estimate the estimands of interest described in Section 4.3.2. The
inference is complicated by a small sample size, large number of parameters, and
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Table 4.7: Summary of diagnostics for HMC-within-Gibbs and MHMC-within-Gibbs
algorithms, applied to Example 2 described in Section 4.4.3. Symbol “00” denotes
no exclusion restrictions, “01” denotes an exclusion restriction on always-takers only,
“10” denotes an exclusion restriction on never-takers only, and “11” denotes exclusion
restrictions on both never-takers and always-takers. Also, piψ and piβ denote log-
posteriors for each set of parameters. The HMC algorithm is superior for the vast
majority of estimates.
HMC
Exclusion type 00 01 10 11
Parameters GR ESS GR ESS GR ESS GR ESS
piψ 1.02 735 1.03 764 1.05 736 1.03 756
piβ 1.48 67 1.60 145 1.07 456 1.01 1173
ITTC 1.28 75 1.45 125 1.04 273 1.05 547
ITTN 1.35 64 1.43 126 1.03 697 1.01 1279
ITTA 1.08 157 1.01 3239 1.09 214 1.02 3623
MHMC
Exclusion type 00 01 10 11
Parameters GR ESS GR ESS GR ESS GR ESS
piψ 1.32 117 1.17 172 1.39 117 1.47 131
piβ 3.01 46 5.14 136 1.60 110 1.19 248
ITTC 3.5 55 4.49 80 1.58 67 1.20 95
ITTN 3.15 161 4.39 291 1.05 455 1.07 454
ITTA 2.65 337 1.05 2595 2.16 227 1.04 2173
missingness in the outcomes. Therefore, we do not attempt to use MHMC algorithm
on these data. Appendix C.1 outlines the computational details, including Gibbs
steps and HMC specifics for posterior computations.
The resulting estimates are summarized in Table 4.8. Overall, the conclusion from
the analysis is the same as the one obtained initially, i.e., the treatment and control
groups do not differ in the rates of adverse events. However, our current analysis is
more accurate because it estimates treatment effects for subsets of patients for which
both potential outcomes are well-defined.
Table 4.9 shows estimated average percentages of units per each strata. Although
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Table 4.8: Posterior median and 95% posterior intervals for estimands of interest
listed in Section 4.3.2, estimated for the clinical trial under consideration using HMC
algorithm. As expected, there is no indication of increased rate of adverse events in
the treatment group, as compared to the rates in the control group. In addition, PS
method allowed us to estimate the rates of death under the treatment and under the
control at each of two time points.
Parameter Median 95% Posterior Interval
δ1 −0.03 (−0.40, 0.21)
δ2 −0.01 (−0.24, 0.18)
ξ01 0.17 (0.03, 0.21)
ξ11 0.01 (0, 0.03)
ξ02 0.04 (0.01, 0.18)
ξ12 0.19 (0.17, 0.21)
Table 4.9: Average percentage of units estimated for each strata defined in Table 4.4.
aa pa na pp np nn
0.790 0.005 0.077 0.004 0.115 0.009
in the initial analysis of these data, described in Chapter 4.9, it was essentially as-
sumed that all subjects belonged to strata aa, the results obtained here indicate that
an estimated 20% of subjects would not survive until the end of the study under one
(or both) of the treatment(s).
To summarize, in this chapter we reviewed PS framework and the attendant as-
sumptions. Then we introduced the HMC-within-Gibbs algorithm that is especially
suitable for sampling from the posterior distribution of the parameters in PS, which
is usually complicated by weak identifiability of the model. We demonstrated the
superiority of the HMC algorithm over a traditional MHMC-within-Gibbs method
on two real-data examples, and, finally, we applied the described method to the data
from a medical device clinical trial. Although the actual conclusion has not changed,
the analysis showed that there is evidence that the data support the PS model.
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Conclusion
Nearly a century-long effort of developing and studying methods of handling miss-
ing data had a major breakthrough in 1970th, when in a series of publications by D.
B. Rubin and other statisticians it was proposed to treat missingness as a random
process. This idea helped to formalize the problem of dealing with missing data by
reformulating it as a problem of modeling missingness mechanism. A plethora of new
methods has been proposed since then, transforming the ways that missing data are
treated.
With the formalization of the problem came the realization that almost all meth-
ods of missing data handling rely on unassessable assumptions about the nature of the
missingness mechanism. Many recently issued guidelines for handling missing data
emphasize the need for standardization of requirements for reporting missing data
and methods of conducting sensitivity analyses in empirical studies (Burzykowski
et al. 2010; CHMP 2010; NRC-Panel 2010). However, recommendations for specific
features and characteristics of missing data that have to be reported as well as for
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methods of performing systematic sensitivity analyses are still scarce, and there is lit-
tle consensus in the field. In Chapter 1 we gave an overview of modern classification
of missing data mechanisms and methods for parameter estimation for incomplete
data. We also provided some recommendations on reporting missing data, including
informative summaries and graphical representations that should be part of every
experimental or observational study report.
In Chapters 2 and 3 we developed a general method of sensitivity analysis of
study’s conclusions to assumptions about missing data. The method uses graphical
displays to demonstrate sensitivity of the estimate of the treatment effect to alterna-
tive missing data specifications and to identify tipping points of the study. In Chapter
2 we described a basic version of enhanced TP displays that help visualize the results
of sensitivity analyses for studies with binary outcomes. In Chapter 3 we generalized
this idea and proposed a systematic way of performing sensitivity analyses based on a
pattern-mixture decomposition of a joint model for outcomes and missingness indica-
tors. In addition, we presented a series of sensitivity parameters that can be used to
explore alternative models for the missingness mechanism and to assess the strength
of the study’s conclusions.
Finally, in Chapter 4, we described another method of performing sensitivity anal-
yses using PS framework. We also proposed an improved method of computation
using HMC algorithm, which accelerates posterior calculations under the PS. All to-
gether, the proposed approaches form a novel collection of useful tools for the analysis
of data sets plagued with missing values.
113
Appendix A
Missing Data Handling
A.1 Violation of Distinctness Under MAR
Let Y = (y1, . . . , yN)
′
, X obs = X and yi = θxi + i, where i ∼
N(0, σ2) and σ is known. Let’s consider two types of censoring of outcomes Y . For
the first one, all units with yi < c, where c is a know constant, will be considered
missing, then Y obs = {yi : yi < c} = (ym1 , ym2 , . . . , ymr)′ , r ≤ N . For the second
one, Y˜ obs = {yi : θxi < c} = (yn1 , yn2 , . . . , ynr˜)′ , r˜ ≤ N . Also, let D and D˜ be the
corresponding vectors of missingness indicators.
On the surface, these two mechanisms are quite similar, however a closer look
reveals fundamental differences. The following is the joint density for the observed
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data in the first case:
f(Y obs,D | X, θ) =
r∏
i=1
f(ymi , dmi | xmi , θ)
N∏
i=r+1
f(dmi | xmi , θ)
=
r∏
i=1
f(ymi | xmi , θ)P (ymi ≥ c | xmi , ymi , θ)
N∏
i=r+1
P (ymi < c | xmi , θ)
=
r∏
i=1
φ
(
ymi − θxmi
σ
) N∏
i=r+1
Φ
(
ymi − θxmi
σ
<
c− θxmi
σ
)
,
where indexes mr+1 through mN correspond to censored units. Last equality holds
because, for mi ≤ r (respondents), P (ymi ≥ c|xmi , ymi , θ) = 1. Here φ(·) is a standard
Normal probability distribution function, and Φ(·) is a corresponding cumulative
distribution function. Clearly, the second product, which models the missing data
mechanism, can not be dropped from the likelihood of θ. Therefore, MLE estimate
will not correspond to an estimate obtained by regressing observed outcomes on X
(i.e., CCA). Another way to look at it is that censoring based on values of Y leads to
a violation of a fundamental assumption of normality in the linear regression, because
(ymi − θxmi)|θ, xmi is now distributed as a truncated normal Nc+(0, σ2).
On the other hand, under the second scenario,
f(Y˜ obs, D˜ | X, θ) =
r˜∏
i=1
f(yni | dni , xni , θ)
N∏
i=r˜+1
f(dni | xni , θ)
=
r˜∏
i=1
f(yni | xni , θ)P (θxni ≥ c | xni , yni , θ)
N∏
i=r˜+1
P (θxni < c | xni , θ)
=
r˜∏
i=1
φ
(
yni − θxni
σ
)
I(θxni ≥ c)
N∏
i=r˜+1
I(θxni < c).
Here, the conditional distribution of Y˜ obs given X is Normal and the standard CCA
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analysis would produce unbiased estimates of θ.
However, there is a way to gain more efficiency in the second scenario. Notice
that θ = φ, i.e., it is a special case of nonignorable missing data with MAR mecha-
nism. Since parameters are not distinct, we can get more precise estimates of θ by
maximizing the likelihood L(θ | Y˜ obs) =
∏r˜
i=1 φ
(
yni−θxni
σ
)
and use the following N
constrains to improve the precision of the estimate for θ,
θxni ≥ c for i ≥ r˜,
θxni < c for i < r˜.
As an immediate corollary, we can notice that the smaller the error σ is the closer
these two quantities are P (yi > c) ≈ P (θxi > c). Therefore, the better the pre-
dictive model is for Y | X, θ, the closer the (possibly) MNAR mechanism may be
approximated by MAR.
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ETP Displays
B.1 Minimal Sufficiency for EF and NEF
Many regularly used distributions belong to a class of exponential families (EF).
Definition B.1.1. The distribution of a random variable Y is a member of an EF
of order one (EF1) if its density has the following form
f(y) = exp{s(y)η(θ)− b(θ) + c(y)},
where θ is a scalar parameter.
Here, η(·) is a function of θ called the natural parameter, s(y) is called natural
observation, and ψ(η) ≡ b(θ) is a cumulant function. If s(y) is linear, the family
becomes a natural EF1 (NEF1). For an i.i.d. sample y1, y2, . . . , yN from an NEF1
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with s(y) = y, the likelihood for θ is proportional to
exp(η(θ)
∑
yi −Nb(θ)).
Therefore,
∑
yi (or y¯) is a minimal sufficient statistic (MSS) for θ. As discussed in
Section 3.2, if Y is the outcome of interest and its distribution is of an NEF1 type,
then the use of ETP displays for the purpose of sensitivity analyses of the treatment
effect to missing data becomes straightforward, because the one-dimensional MSS
provides a natural data summary that can be represented by horizontal and vertical
axes.
Some commonly used distributions are members of a particular subclass of NEF1
with quadratic variance function (NEF-QVF, Morris 1982, 1983; Morris and Lock
2009). If Y is distributed as NEF-QVF with µ ≡ E(Y | θ) = ψ′(η), then V ar(Y | θ) =
ψ′′(η) = υ2µ2 + υ1µ + σ0, where υ1, υ2 and σ0 are known. This class includes the
following six distributions:
• Normal distribution with known variance σ0, N(µ, σ0), η = µ;
• Poisson distribution Pois(µ), η = log(µ);
• Exponential distribution with scale parameter µ, µExpo(1), and a scaled
Gamma distribution with known shape parameter α, µGam(α), with η =
1− 1/µ;
• Bernoulli distribution Bern(p), with p = µ, and Binom(N, p) with known N
and η = log(p/(1− p));
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• Geometric distribution Geom(p), with µ = p/(1 − p) and η = log(2p), and
Negative binomial NegBinom(r, p) with known convolution parameter r;
• Less commonly used, but still quite handy, Convolved Hyperbolic Secant dis-
tribution, CHS(µ); it is skewed with support on the real line and η = tan−1(µ).
Many applied modeling problems can be addressed by employing EFs. However,
as seen from the Definition B.1.1, every EF1 is a non-linear transformation of a
corresponding NEF1, e.g., Lognormal, Weibull, Pareto, Chi, Power Function, Inverted
Gamma etc. If the distribution of Y is EF1 and s(y) is a monotone function, then
the problem can be reduced back to the NEF1 case by working with a transformed
variable z = s(y), so that the MSS for the problem becomes
∑
zi. This expands the
pool of distributions for which the ETP displays can be used straightaway.
Finally, the preceding discussion can be generalized to models with several pa-
rameters by defining an EF of order p (EFp).
Definition B.1.2. The distribution of a random variable Y is a member of EFp if
its density has the following form
f(y) = exp{s(y)Tη(θ)− b(θ) + c(y)},
where s(y) = (s1(y), s2(y), . . . , sp(y))
′
, η = (η1, η2, . . . , ηp)
′
and θ = (θ1, θ2, . . . , θq)
′
.
If p, which is also the dimension of the sufficient statistic, does not match q, the
dimension of the parameter-vector, then the family is called curved EFs. Models with
q > p are generally not useful because, in this case, θ can not be identified from the
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data. If p = q and η(θ) is a 1-to-1 mapping then the MSS for θ is
(
N∑
i=1
s1(yi),
N∑
i=1
s2(yi), . . . ,
N∑
i=1
sp(yi)).
This provides a natural way to generalize ETP displays to problems with outcomes
modeled as an EFp. It can be done by fixing some components of the MSS while
plotting the others, as illustrated in Section 3.2.1 for a Normal model with unknown
mean and variance.
However, if the parameter of interest is a component of a multiple regression
coefficient β from f(Y |X,β), the choice of the convenient summary is less apparent.
Given a canonical link function, the MSS for β in GLM is a vector XTY (McCullagh
and Nelder 1989), and further research is needed to find the best and most intuitive
way to reduce this MSS to a one-dimensional summary.
B.2 Approximate Degrees of Freedom
The proof of Theorem 3.2.2 is based on matching first two moments of the distri-
bution of the squared denominator in (3.4) to a scaled chi-square distribution. Let
s2d =
s21
NT
+
s20
NC
, then
s2d | σ20, σ21 ∼
σ21χ
2
NTobs
NTNTobs
+
σ20χ
2
NCobs
NCNCobs
,
where χ2
NTobs
and χ2
NCobs
are two independent chi-square distributions. The mean and
variance of s2d are the following
E(s2d | σ20, σ21) = σ21/NT+σ20/NC , V ar(s2d | σ20, σ21) = 2
(
(σ21/N
T )2/NTobs + (σ
2
0/N
C)2/NCobs
)
.
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Let’s consider a new chi-square distribution, with scale parameter s˜2 and degrees of
freedom f˜ , that has the same first two moments as s2d. Then,
s˜2f˜ = σ21/N
T + σ20/N
C ,
s˜4f˜ = (σ21/N
T )2/NTobs + (σ
2
0/N
C)2/NCobs.
It follows that
f˜ =
(σ21/N
T + σ20/N
C)2
(σ21/N
T )2/NTobs + (σ
2
0/N
C)2/NCobs
.
Finally, ˆ˜f in (3.5) is obtained by substituting σ2i with s
2
i , i = 0, 1. The discussion of
the validity of the test under the derived approximation presented in Welch (1938)
applies to the current modification.
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HMC Algorithm for PS Framework
C.1 Bayesian Updating for PS Framework with
HMC Steps
The sampler described below calculates the posterior of estimands of interest by
iterating between imputing missing principal strata conditional on the current set
of parameter draws, then drawing from the posterior distribution of the parameters
conditional on the imputed strata using HMC, and finally using the results from
the previous two steps to impute missing outcomes and calculate the estimands of
interest.
The model for the clinical trial under consideration was set up in Section 4.3.3. A
series of assumptions and simplifications resulted in the following vector of parame-
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ters,
θ =(βaa,110, βpa,110, βpp,110, βaa,111, βpa,111, βna,111,
βpp,111, βnp,111, βaa,120, βaa,121, βpa,121, βna,121,
βaa,210, βpa,210, βpp,210, βaa,211, βpa,211, βna,211,
βpp,211, βnp,211, βaa,220, βaa,221, βpa,221, βna,221,
βaa,310, βpa,310, βpp,310, βaa,311, βpa,311, βna,311,
βpp,311, βnp,311, βaa,320, βaa,321, βpa,321, βna,321,
β1, β2, ψaa, ψpa, ψpp, ψna, ψnp, ψ1, ψ2, ψ3, ψ4).
Here, to keep the notation uncluttered, we renamed ψh ≡ ψh,0 and βh,rtz ≡ βh,rtz,0.
Let
Ψs(xi) =
exp(ψs,0 + ψ1xi1 + ψ2xi2 + ψ3xi3 + ψ4xi4)∑
h∈Ω exp (ψh,0 + ψ1xi1 + ψ2xi2 + ψ3xi3 + ψ4xi4)
,
Γ(xi, βs,rtz) =
exp (βs,rtz + β1xi5 + β2xi6)
1 + exp (βs,rtz + β1xi5 + β2xi6)
.
Also, let
Φs(i, t) =Γ(xi, βs,1tzi)
y1i,t(zi) (1− Γ(xi, βs,1tzi))5−y1i,t(zi)×
Γ(xi, βs,2tzi)
y2i,t(zi) (1− Γ(xi, βs,2tzi))1−y2i,t(zi)×
Γ(xi, βs,3tzi)
y3i,t(zi) (1− Γ(xi, βs,3tzi))1−y3i,t(zi) .
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Then, the likelihood in (4.2) is proportional to the following:
Φ =
∏
i:si=aa
Ψaa(xi)Φaa(i, 1)Φaa(i, 2) ·
∏
i:si=pa
Ψpa(xi)Φpa(i, 1) [Φpa(i, 2)]
zi · (C.1)
∏
i:si=pp
Ψpp(xi)Φpp(i, 1) ·
∏
i:si=na
Ψna(xi) [Φna(i, 1)Φna(i, 2)]
zi ·
∏
i:si=np
Ψnp(xi) [Φnp(i, 1)]
zi ·
∏
i:si=nn
Ψnn(xi).
We assume that all parameters are a priori independent and follow Normal distri-
butions with mean 0 and standard deviation 2.5. Also, all continuous covariates are
standardized to have mean 0 and standard deviation 2.5.
Sampling from the posterior, which is proportional to C.1, is fairly straightforward.
The estimation algorithm consists of the following steps:
0. Initialize latent strata S ;
1. Update parameters θ = (ψ,β) given latent strata using HMC. Conditional on S ,
the vectors of parameters ψ and β are independent a posteriori, and the gradient
of the logarithm of each posterior can be obtained in closed-form. Suppose the
current draw is θ(t). The HMC algorithm to sample each ψ and β separately
consists of the following steps:
• Sample new momentum vector p(0) from a multivariate Gaussian distri-
bution.
• Perform L steps of the Leapfrog algorithm Hockney (1970), starting at
θ(t)(0) ≡ θ(t) and p(0), to obtain a new proposal (θ(t)(L), p(L)) for the aug-
mented parameters space. The algorithm uses the following approximation
124
Appendix C: HMC Algorithm for PS Framework
to update parameters (position) θ and momentum p:
p(t+ /2) = p(t)− 
2
∂H(θ,p)
∂θ
∣∣∣∣
t
,
θ(t+ ) = θ(t) + p(t+ /2)Λ−1,
p(t+ ) = p(t+ /2)− 
2
∂H(θ,p)
∂θ
∣∣∣∣
t+
.
• Accept the new proposal, i.e. let θ(t+1) = θ(t)(L), with the probability
min{1, exp
(
H(θ(t)(0), p(0))
)
exp (H(θ(t)(L), p(L)))
},
otherwise, let θ(t+1) = θ(t). This rule is similar to the one used in MHMC,
except that here the acceptance probability depends on the ratio of “ener-
gies” at the current state and at the end state of the leap-frog path.
2. Impute latent strata given updated parameters. The distribution of S condi-
tional on observed data and model parameters θ is easy to calculate by Bayes’
theorem. For that, we use Table 4.5 to identify what strata are possible for
each subject, given their treatment group and observe outcomes. If there is
more than one possible stratum, then we use multinomial distribution to select
it probabilistically. For example, if ti = 1 and di,1 = di,2 = 0, then the subject
can belong to stratum aa, pa, or na. In order choose one, we sample from
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Multinom
(
1,
(
ρaa
ρ
, ρpa
ρ
, ρna
ρ
))
, where
ρaa =Ψaa(xi)Φaa(i, 1)Φaa(i, 2),
ρpa =Ψpa(xi)Φpa(i, 1)Φpa(i, 2),
ρna =Ψna(xi)Φna(i, 1)Φna(i, 2),
ρ =ρaa + ρpa + ρna.
3. Given the values of parameters and sampled strata, impute missing outcomes
using models 4.4 and 4.5. Steps 1-3 are iterated until convergence.
4. Estimate the estimands of interest: δ1, δ2, ξ
z
1 , and ξ
z
2 , z ∈ {0, 1}.
We set the HMC leapfrog step size to ψ = 0.05 and take Lψ = 10 leapfrog steps for
parameters ψ, and also set β = 0.05 and Lβ = 10 for parameters β . We produce
three chains of length 100,000 and discard first 30% burn-in draws.
C.2 Data and Models for Example 1
Table C.1 summarizes the observed data used for Example 1 in Section 4.4.2.
The following assumptions on the potential outcomes were employed,
yi(0) ⊥ yi(1) | xi, θ, (C.2)
zi | yi(0), yi(1), di(0), di(1), di,xi, θ ∼ zi | xi, θ, (C.3)
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Table C.1: Observed outcomes in the Gerber and Green (2000) field trial. The data is
limited to single-occupancy homes, with individuals assigned to receive the personal
canvassing treatment (and no other treatments) or those assigned no treatment at
all.
Assignment Canvassed Voted
zobsi d
obs
i y
obs
i # Subjects (N = 6617) Strata
0 0 0 3168 c or n
0 0 1 2101 c or n
1 0 0 595 c
1 0 1 381 n
1 1 0 163 c
1 1 1 209 c
Ψ(xi) = Pr (si = c | xi;θ) = 1− Pr(si = n | xi;θ)
=
exp(ψ0 + ψ1xi1 + ψ2xi2 + ψ3xi3 + ψ4xi4)
1 + exp(ψ0 + ψ1xi1 + ψ2xi2 + ψ3xi3 + ψ4xi4)
,
Γ(xi, βsz0) = Pr (yi(zi) = 1 | si = s, zi = z,xi;θ)
=
exp(βsz0 + β0·1xi1 + β0·2xi2 + β0·3xi3 + β0·4xi4)
1 + exp(βsz0 + β0·1xi1 + β0·2xi2 + β0·3xi3 + β0·4xi4)
.
The assumption on the assignment mechanism (C.3) is justified by the study design.
There are a total of 13 parameters in this model,
θ = (ψ0, ψ1, ψ2, ψ3, ψ4, βc00, βc10, βn00, βn10, β0·1, β0·2, β0·3, β0·4).
We assume that intercepts and slopes follow Cauchy distributions with scale 2.5
independently a priori. Continuous covariates are standardized to have mean 0 and
standard deviation 2.5. The crucial piece of missing data in this study are compliances
for subjects assigned control who receive control.
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The complete-data likelihood has the following form:
∏
i:si=c
[ ∏
i∈(0,0)
{
Ψ(xi)× Γ(xi, βc00)yi (1− Γ(xi, βc00))1−yi
}
∏
i∈(1,0)
{
Ψ(xi)× Γ(xi, βc10)yi (1− Γ(xi, βc10))1−yi
} ]×
∏
i:si=n
[ ∏
i∈(0,0)
{
(1−Ψ(xi))× Γ(xi, βn00)yi (1− Γ(xi, βn00))1−yi
}×
∏
i∈(1,0)
{
(1−Ψ(xi))× Γ(xi, βn10)yi (1− Γ(xi, βn10))1−yi
} ]
,
(C.4)
where yi = yi(1)di(zi) + yi(0){1 − di(zi)}, and i ∈ (z, d) if subject i is assigned
treatment z and receives treatment d, where z, d ∈ {0, 1}.
The distribution of S conditional on observed data and model parameters θ is
easily derived. For example, if a subject assigned control receives control, di(0) = 0,
then the conditional probability that the subject is a complier is
Pr (si = c | di(0) = 0,xi;θ) =
Ψ(xi)Γ(xi, βc00)
yi (1− Γ(xi, βc00)1−yi)
Ψ(xi)Γ(xi, βc00)yi (1− Γ(xi, βc00)1−yi) + (1−Ψ(xi))Γ(xi, βn00)yi (1− Γ(xi, βn00)1−yi)
We set the HMC leapfrog step size to ψ = 0.04 and take Lψ = 100 leapfrog
steps for parameters ψ, and also set β = 0.03 and Lβ = 50 for parameters β .
Again, parameters ψ and β are independent a posteriori conditional on imputed
S . As such, HMC is performed independently for these two sets of parameters to
ensure numerical stability: it is crucial to calculate the Cholesky decomposition of
the mass matrix when performing the leapfrog steps, and splitting θ into the two
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sets helps prevent numerical errors. Another model considered by Gill et al. (2013)
uses exclusion restriction by assuming βn00 = βn10. We apply HMC algorithm to this
model as well, with the change that Lβ = 75.
C.3 Data and Models for Example 2
Table C.2 summarizes the observed data used for Example 2 in Section 4.4.3.
Table C.2: Observed outcomes in the Hirano et al. (2000) analysis.
Encouragement Vaccination Hospitalization
zobsi d
obs
i c
obs
i # Subjects Strata
0 0 0 1040 c or n
0 0 1 99 c or n
0 1 0 237 a
0 1 1 30 a
1 0 0 944 n
1 0 1 85 n
1 1 0 424 c or a
1 1 1 31 c or a
A summary of our model assumptions is below.
yi(0) ⊥ yi(1) | xi, θ,
zi | yi(0), yi(1), di(0), di(1), si,xi, θ ∼ zi | xi, θ,
Ψc(xi) = Pr(si = c | xi, θ) = exp(ψc0 + ψc1xi1 + ψc2xi2)
1 + exp(ψc0 + ψc1xi1 + ψc2xi2) + exp(ψa0 + ψa1xi1 + ψa2xi2)
,
Ψa(xi) = Pr(si = a | xi, θ) = exp(ψa0 + ψa1xi1 + ψa2xi2)
1 + exp(ψc0 + ψc1xi1 + ψc2xi2) + exp(ψa0 + ψa1xi1 + ψa2xi2)
,
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Γ(xi, βsz0) = Pr {yi(zi) = 1 | si = s, zi = z,xi, θ} =
exp(βsz0 + β0·1xi1 + β0·2xi2 + β0·3xi3 + β0·4xi4)
1 + exp(βsz0 + β0·1xi1 + β0·2xi2 + β0·3xi3 + β0·4xi4)
,
θ = (ψc0, ψc1, ψc2, ψa0, ψa1, ψa2, βc00, βc10, βn00, βn10, βa00, βa10, β0·1, β0·2).
Again, intercepts and slopes follow Cauchy distribution with scale 2.5 independently
a priori, and continuous covariates are standardized to have mean 0 and standard
deviation 2.5. The complete-data likelihood follows below.
∏
i:si=c
[ ∏
i∈(0,0)
{
Ψc(xi)× Γ(xi, βc00)yi (1− Γ(xi, βc00))1−yi
}
∏
i∈(1,1)
{
Ψc(xi)× Γ(xi, βc10)yi (1− Γ(xi, βc10))1−yi
} ]×
∏
i:si=a
[ ∏
i∈(0,1)
{
Ψa(xi)× Γ(xi, βa00)yi (1− Γ(xi, βa00))1−yi
}×
∏
i∈(1,0)
{
Ψa(xi)× Γ(xi, βa10)yi (1− Γ(xi, βa10))1−yi
} ]
∏
i:si=n
[ ∏
i∈(0,0)
{
(1−Ψc(xi)−Ψa(xi))× Γ(xi, βn00)yi (1− Γ(xi, βn00))1−yi
}×
∏
i∈(1,0)
{
(1−Ψc(xi)−Ψa(xi))× Γ(xi, βn10)yi (1− Γ(xi, βn10))1−yi
} ]
Note that there are four different models under consideration, depending on whether
the exclusion restriction is placed on never-takers (βn00 = βn10) or always-takers
(βa00 = βa10). Figures C.1 and C.2 show autocorrelation plots of draws generated for
the case with no exclusion restrictions.
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Figure C.1: Autocorrelation plots of draws produced by HMC algorithm in Example
2, described in Section 4.4.3, for the case with exclusion restrictions.
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Figure C.2: Autocorrelation plots of draws produced by MHMC algorithm in Example
2, described in Section 4.4.3, for the case with exclusion restrictions. Again, when
comparing to the plots in Figure C.1, it is evident that the correlations between
consecutive and near-consecutive draws are much higher for MHMC.
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